메뉴 건너뛰기




Volumn 58, Issue 25, 2011, Pages 2703-2738

2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DABIGATRAN; DIGITALIS; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISOPYRAMIDE; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; INOTROPIC AGENT; NIFEDIPINE; NORADRENALIN; PHENYLEPHRINE; VASODILATOR AGENT; VERAPAMIL;

EID: 83055162256     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.10.825     Document Type: Article
Times cited : (227)

References (371)
  • 1
    • 78650706231 scopus 로고    scopus 로고
    • ACCF/AHA Task Force on Practice Guidelines http://assets.cardiosource. com/Methodology-Manual-for-ACC-AHA-Writing-Committees.pdf Accessed July 11, 2011
    • ACCF/AHA Task Force on Practice Guidelines Methodologies and Policies from the ACCF/AHA Task Force on Practice Guidelines http://circ.ahajournals.org/ site/manual/index.xhtml http://assets.cardiosource.com/Methodology-Manual-for- ACC-AHA-Writing-Committees.pdf Accessed July 11, 2011
    • Methodologies and Policies from the ACCF/AHA Task Force on Practice Guidelines
  • 2
    • 83055190214 scopus 로고    scopus 로고
    • 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • e000000
    • B.J. Gersh, B.J. Maron, and R.O. Bonow 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 58 2011 e000000
    • (2011) J Am Coll Cardiol , vol.58
    • Gersh, B.J.1    Maron, B.J.2    Bonow, R.O.3
  • 3
    • 70449192269 scopus 로고
    • Asymmetrical hypertrophy of the heart in young adults
    • D. Teare Asymmetrical hypertrophy of the heart in young adults Br Heart J 20 1958 1 8
    • (1958) Br Heart J , vol.20 , pp. 1-8
    • Teare, D.1
  • 4
    • 0002206328 scopus 로고
    • Idiopathic Hypertrophic subaortic stenosis, I: A description of the disease based upon an analysis of 64 patients
    • E. Braunwald, C.T. Lambert, and S.D. Rockoff Idiopathic Hypertrophic subaortic stenosis, I: a description of the disease based upon an analysis of 64 patients Circulation 30 suppl 4 1964 119
    • (1964) Circulation , vol.30 , Issue.SUPPL. 4 , pp. 119
    • Braunwald, E.1    Lambert, C.T.2    Rockoff, S.D.3
  • 5
    • 19944434362 scopus 로고    scopus 로고
    • Glycogen storage diseases presenting as hypertrophic cardiomyopathy
    • M. Arad, B.J. Maron, and J.M. Gorham Glycogen storage diseases presenting as hypertrophic cardiomyopathy N Engl J Med 352 2005 362 372
    • (2005) N Engl J Med , vol.352 , pp. 362-372
    • Arad, M.1    Maron, B.J.2    Gorham, J.M.3
  • 6
    • 0037173015 scopus 로고    scopus 로고
    • Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy
    • DOI 10.1161/01.CIR.0000019070.70491.6D
    • C.Y. Ho, N.K. Sweitzer, and B. McDonough Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy Circulation 105 2002 2992 2997 (Pubitemid 34693832)
    • (2002) Circulation , vol.105 , Issue.25 , pp. 2992-2997
    • Ho, C.Y.1    Sweitzer, N.K.2    McDonough, B.3    Maron, B.J.4    Casey, S.A.5    Seidman, J.G.6    Seidman, C.E.7    Solomon, S.D.8
  • 9
    • 0037058868 scopus 로고    scopus 로고
    • Prevalence and severity of benign mutations in the β-myosin heavy chain, cardiac troponin T, and α-tropomyosin genes in hypertrophic cardiomyopathy
    • DOI 10.1161/01.CIR.0000042675.59901.14
    • S.L. Van Driest, M.J. Ackerman, and S.R. Ommen Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy Circulation 106 2002 3085 3090 (Pubitemid 35440293)
    • (2002) Circulation , vol.106 , Issue.24 , pp. 3085-3090
    • Van Driest, S.L.1    Ackerman, M.J.2    Ommen, S.R.3    Shakur, R.4    Will, M.L.5    Nishimura, R.A.6    Tajik, A.J.7    Gersh, B.J.8
  • 11
    • 67649869864 scopus 로고    scopus 로고
    • Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: The patients' perspective
    • I. Christiaans, I.M. van Langen, and E. Birnie Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients' perspective Am J Med Genet A 149A 2009 1444 1451
    • (2009) Am J Med Genet A , vol.149 A , pp. 1444-1451
    • Christiaans, I.1    Van Langen, I.M.2    Birnie, E.3
  • 12
    • 0030776366 scopus 로고    scopus 로고
    • Information recall in genetic counselling: A pilot study of its assessment
    • DOI 10.1016/S0738-3991(97)00068-2, PII S0738399197000682
    • S. Michie, D. French, and A. Allanson Information recall in genetic counselling: a pilot study of its assessment Patient Educ Couns 32 1997 93 100 (Pubitemid 27395983)
    • (1997) Patient Education and Counseling , vol.32 , Issue.1-2 , pp. 93-100
    • Michie, S.1    French, D.2    Allanson, A.3    Bobrow, M.4    Marteau, T.M.5
  • 15
    • 63749118338 scopus 로고    scopus 로고
    • Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: A cross-sectional cohort study
    • I. Christiaans, I.M. van Langen, and E. Birnie Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study Am J Med Genet A 149A 2009 602 612
    • (2009) Am J Med Genet A , vol.149 A , pp. 602-612
    • Christiaans, I.1    Van Langen, I.M.2    Birnie, E.3
  • 19
    • 0026409603 scopus 로고
    • Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes
    • A. Rosenzweig, H. Watkins, and D.S. Hwang Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes N Engl J Med 325 1991 1753 1760
    • (1991) N Engl J Med , vol.325 , pp. 1753-1760
    • Rosenzweig, A.1    Watkins, H.2    Hwang, D.S.3
  • 23
    • 0034680324 scopus 로고    scopus 로고
    • Homozygous mutation in cardiac troponin T: Implications for hypertrophic cardiomyopathy
    • C.Y. Ho, H.M. Lever, and R. DeSanctis Homozygous mutation in cardiac troponin T: implications for hypertrophic cardiomyopathy Circulation 102 2000 1950 1955
    • (2000) Circulation , vol.102 , pp. 1950-1955
    • Ho, C.Y.1    Lever, H.M.2    Desanctis, R.3
  • 24
    • 33646757738 scopus 로고    scopus 로고
    • Compound and double mutations in patients with hypertrophic cardiomyopathy: Implications for genetic testing and counseling
    • J. Ingles, A. Doolan, and C. Chiu Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counseling J Med Genet 42 2005 e59
    • (2005) J Med Genet , vol.42 , pp. 59
    • Ingles, J.1    Doolan, A.2    Chiu, C.3
  • 26
    • 0031922826 scopus 로고    scopus 로고
    • A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated β-myosin heavy chain genes
    • DOI 10.1007/s004390050695
    • B. Jeschke, K. Uhl, and B. Weist A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated beta-myosin heavy chain genes Hum Genet 102 1998 299 304 (Pubitemid 28185218)
    • (1998) Human Genetics , vol.102 , Issue.3 , pp. 299-304
    • Jeschke, B.1    Uhl, K.2    Weist, B.3    Schroder, D.4    Meitinger, T.5    Dohlemann, C.6    Vosberg, H.-P.7
  • 27
    • 69049087629 scopus 로고    scopus 로고
    • Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy
    • I. Christiaans, R.H. Lekanne dit Deprez, and I.M. van Langen Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy Heart Rhythm 6 2009 1366 1369
    • (2009) Heart Rhythm , vol.6 , pp. 1366-1369
    • Christiaans, I.1    Lekanne Dit Deprez, R.H.2    Van Langen, I.M.3
  • 28
    • 61649085881 scopus 로고    scopus 로고
    • Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives
    • P.S. Andersen, O. Havndrup, and L. Hougs Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives Hum Mutat 30 2009 363 370
    • (2009) Hum Mutat , vol.30 , pp. 363-370
    • Andersen, P.S.1    Havndrup, O.2    Hougs, L.3
  • 29
    • 77950521751 scopus 로고    scopus 로고
    • The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: Focus on predictive screening
    • I. Christiaans, E. Birnie, and I.M. van Langen The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening Eur Heart J 31 2010 842 848
    • (2010) Eur Heart J , vol.31 , pp. 842-848
    • Christiaans, I.1    Birnie, E.2    Van Langen, I.M.3
  • 30
    • 70449516390 scopus 로고    scopus 로고
    • Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers
    • M. Michels, O.I. Soliman, and J. Phefferkorn Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers Eur Heart J 30 2009 2593 2598
    • (2009) Eur Heart J , vol.30 , pp. 2593-2598
    • Michels, M.1    Soliman, O.I.2    Phefferkorn, J.3
  • 32
    • 0019520493 scopus 로고
    • Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: A prospective study
    • DOI 10.1016/0002-9149(81)90604-4
    • B.J. Maron, D.D. Savage, and J.K. Wolfson Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study Am J Cardiol 48 1981 252 257 (Pubitemid 11019058)
    • (1981) American Journal of Cardiology , vol.48 , Issue.2 , pp. 252-257
    • Maron, B.J.1    Savage, D.D.2    Wolfson, J.K.3    Epstein, S.E.4
  • 33
    • 0242522154 scopus 로고    scopus 로고
    • American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy
    • B.J. Maron, W.J. McKenna, and G.K. Danielson American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy J Am Coll Cardiol 42 2003 1687 1713
    • (2003) J Am Coll Cardiol , vol.42 , pp. 1687-1713
    • Maron, B.J.1    McKenna, W.J.2    Danielson, G.K.3
  • 35
    • 33751245882 scopus 로고    scopus 로고
    • Determinants for clinical diagnosis of hypertrophic cardiomyopathy
    • DOI 10.1016/j.amjcard.2006.07.029, PII S0002914906016420
    • A.S. Adabag, M.A. Kuskowski, and B.J. Maron Determinants for clinical diagnosis of hypertrophic cardiomyopathy Am J Cardiol 98 2006 1507 1511 (Pubitemid 44781428)
    • (2006) American Journal of Cardiology , vol.98 , Issue.11 , pp. 1507-1511
    • Adabag, A.S.1    Kuskowski, M.A.2    Maron, B.J.3
  • 36
    • 56049107035 scopus 로고    scopus 로고
    • Echocardiography in hypertrophic cardiomyopathy: The role of conventional and emerging technologies
    • L.C. Afonso, J. Bernal, and J.J. Bax Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies JACC Cardiovasc Imaging 1 2008 787 800
    • (2008) JACC Cardiovasc Imaging , vol.1 , pp. 787-800
    • Afonso, L.C.1    Bernal, J.2    Bax, J.J.3
  • 37
    • 38349160674 scopus 로고    scopus 로고
    • Management of symptoms in hypertrophic cardiomyopathy
    • M.A. Fifer, and G.J. Vlahakes Management of symptoms in hypertrophic cardiomyopathy Circulation 117 2008 429 439
    • (2008) Circulation , vol.117 , pp. 429-439
    • Fifer, M.A.1    Vlahakes, G.J.2
  • 38
    • 0028849972 scopus 로고
    • Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients
    • H.G. Klues, A. Schiffers, and B.J. Maron Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients J Am Coll Cardiol 26 1995 1699 1708
    • (1995) J Am Coll Cardiol , vol.26 , pp. 1699-1708
    • Klues, H.G.1    Schiffers, A.2    Maron, B.J.3
  • 40
    • 61849140724 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy: Current understanding and treatment objectives
    • G.S. Soor, A. Luk, and E. Ahn Hypertrophic cardiomyopathy: current understanding and treatment objectives J Clin Pathol 62 2009 226 235
    • (2009) J Clin Pathol , vol.62 , pp. 226-235
    • Soor, G.S.1    Luk, A.2    Ahn, E.3
  • 41
    • 0022390809 scopus 로고
    • Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review
    • DOI 10.1016/0033-0620(85)90024-6
    • E.D. Wigle, Z. Sasson, and M.A. Henderson Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy: a review Prog Cardiovasc Dis 28 1985 1 83 (Pubitemid 15237515)
    • (1985) Progress in Cardiovascular Diseases , vol.28 , Issue.1 , pp. 1-83
    • Wigle, E.D.1    Sasson, Z.2    Henderson, M.A.3
  • 42
    • 0029118518 scopus 로고
    • Hypertrophic cardiomyopathy: Clinical spectrum and treatment
    • E.D. Wigle, H. Rakowski, and B.P. Kimball Hypertrophic cardiomyopathy: clinical spectrum and treatment Circulation 92 1995 1680 1692
    • (1995) Circulation , vol.92 , pp. 1680-1692
    • Wigle, E.D.1    Rakowski, H.2    Kimball, B.P.3
  • 43
    • 33645655544 scopus 로고    scopus 로고
    • Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: Septal morphological features predict the presence of myofilament mutations
    • J. Binder, S.R. Ommen, and B.J. Gersh Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations Mayo Clin Proc 81 2006 459 467
    • (2006) Mayo Clin Proc , vol.81 , pp. 459-467
    • Binder, J.1    Ommen, S.R.2    Gersh, B.J.3
  • 44
    • 67649854428 scopus 로고    scopus 로고
    • Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy
    • J.M. Bos, J.A. Towbin, and M.J. Ackerman Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy J Am Coll Cardiol 54 2009 201 211
    • (2009) J Am Coll Cardiol , vol.54 , pp. 201-211
    • Bos, J.M.1    Towbin, J.A.2    Ackerman, M.J.3
  • 45
    • 77649185345 scopus 로고    scopus 로고
    • Progress with genetic cardiomyopathies: Screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy
    • R.E. Hershberger, J. Cowan, and A. Morales Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy Circ Heart Fail 2 2009 253 261
    • (2009) Circ Heart Fail , vol.2 , pp. 253-261
    • Hershberger, R.E.1    Cowan, J.2    Morales, A.3
  • 46
    • 4344705206 scopus 로고    scopus 로고
    • Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy
    • DOI 10.1016/j.jacc.2004.08.052, PII S0735109704017425
    • B.J. Maron, J.G. Seidman, and C.E. Seidman Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy J Am Coll Cardiol 44 2004 2125 2132 (Pubitemid 39576030)
    • (2004) Journal of the American College of Cardiology , vol.44 , Issue.11 , pp. 2125-2132
    • Maron, B.J.1    Seidman, J.G.2    Seidman, C.E.3
  • 48
    • 10844223722 scopus 로고    scopus 로고
    • Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy
    • DOI 10.1136/hrt.2003.030353
    • P.P. Dimitrow, and J.S. Dubiel Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic cardiomyopathy Heart 91 2005 93 94 (Pubitemid 39665005)
    • (2005) Heart , vol.91 , Issue.1 , pp. 93-94
    • Dimitrow, P.P.1    Dubiel, J.S.2
  • 49
    • 68949188142 scopus 로고    scopus 로고
    • Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy
    • G.K. Efthimiadis, D.G. Parcharidou, and G. Giannakoulas Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy Am J Cardiol 104 2009 695 699
    • (2009) Am J Cardiol , vol.104 , pp. 695-699
    • Efthimiadis, G.K.1    Parcharidou, D.G.2    Giannakoulas, G.3
  • 51
    • 0034702926 scopus 로고    scopus 로고
    • Epidemiology of hypertrophic cardiomyopathy-related death: Revisited in a large non-referral-based patient population
    • B.J. Maron, I. Olivotto, and P. Spirito Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population Circulation 102 2000 858 864
    • (2000) Circulation , vol.102 , pp. 858-864
    • Maron, B.J.1    Olivotto, I.2    Spirito, P.3
  • 53
    • 52649134379 scopus 로고    scopus 로고
    • Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: Past, present and future
    • S.R. Ommen, P.M. Shah, and A.J. Tajik Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future Heart 94 2008 1276 1281
    • (2008) Heart , vol.94 , pp. 1276-1281
    • Ommen, S.R.1    Shah, P.M.2    Tajik, A.J.3
  • 54
    • 67649611183 scopus 로고    scopus 로고
    • Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: A long-term follow-up study
    • P. Sorajja, R.A. Nishimura, and B.J. Gersh Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study J Am Coll Cardiol 54 2009 234 241
    • (2009) J Am Coll Cardiol , vol.54 , pp. 234-241
    • Sorajja, P.1    Nishimura, R.A.2    Gersh, B.J.3
  • 55
    • 0026767163 scopus 로고
    • Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: Clarification of pathophysiology and importance in intraoperative decision making
    • L.E. Grigg, E.D. Wigle, and W.G. Williams Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: clarification of pathophysiology and importance in intraoperative decision making J Am Coll Cardiol 20 1992 42 52
    • (1992) J Am Coll Cardiol , vol.20 , pp. 42-52
    • Grigg, L.E.1    Wigle, E.D.2    Williams, W.G.3
  • 56
    • 0026453667 scopus 로고
    • Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy
    • T.H. Marwick, W.J. Stewart, and H.M. Lever Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy J Am Coll Cardiol 20 1992 1066 1072
    • (1992) J Am Coll Cardiol , vol.20 , pp. 1066-1072
    • Marwick, T.H.1    Stewart, W.J.2    Lever, H.M.3
  • 57
    • 0033667411 scopus 로고    scopus 로고
    • Mitral regurgitation in hypertrophic obstructive cardiomyopathy: Relationship to obstruction and relief with myectomy
    • E.H. Yu, A.S. Omran, and E.D. Wigle Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy J Am Coll Cardiol 36 2000 2219 2225
    • (2000) J Am Coll Cardiol , vol.36 , pp. 2219-2225
    • Yu, E.H.1    Omran, A.S.2    Wigle, E.D.3
  • 59
    • 13944284173 scopus 로고    scopus 로고
    • Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy
    • DOI 10.1016/j.amjcard.2004.08.030
    • D. Monakier, A. Woo, and T. Puri Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy Am J Cardiol 94 2004 1515 1522 (Pubitemid 40268453)
    • (2004) American Journal of Cardiology , vol.94 , Issue.12 , pp. 1515-1522
    • Monakier, D.1    Woo, A.2    Puri, T.3    Schwartz, L.4    Ross, J.5    Jamorski, M.6    Yang, H.7    Liu, Z.8    Vannan, M.9    Wigle, E.D.10    Rakowski, H.11
  • 61
    • 47649084105 scopus 로고    scopus 로고
    • Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy
    • P. Sorajja, U. Valeti, and R.A. Nishimura Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy Circulation 118 2008 131 139
    • (2008) Circulation , vol.118 , pp. 131-139
    • Sorajja, P.1    Valeti, U.2    Nishimura, R.A.3
  • 62
    • 43049156599 scopus 로고    scopus 로고
    • Myocardial mechanics explains the time course of benefit for septal ethanol ablation for hypertrophic cardiomyopathy
    • S. Carasso, A. Woo, and H. Yang Myocardial mechanics explains the time course of benefit for septal ethanol ablation for hypertrophic cardiomyopathy J Am Soc Echocardiogr 21 2008 493 499
    • (2008) J Am Soc Echocardiogr , vol.21 , pp. 493-499
    • Carasso, S.1    Woo, A.2    Yang, H.3
  • 63
    • 54049088131 scopus 로고    scopus 로고
    • Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: The Baylor and Medical University of South Carolina experience 1996 to 2007
    • V.L. Fernandes, C. Nielsen, and S.F. Nagueh Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: the Baylor and Medical University of South Carolina experience 1996 to 2007 JACC Cardiovasc Interv 1 2008 561 570
    • (2008) JACC Cardiovasc Interv , vol.1 , pp. 561-570
    • Fernandes, V.L.1    Nielsen, C.2    Nagueh, S.F.3
  • 66
    • 8344263111 scopus 로고    scopus 로고
    • Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy
    • DOI 10.1161/01.CIR.0000162460.36735.71
    • A. Woo, W.G. Williams, and R. Choi Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy Circulation 111 2005 2033 2041 (Pubitemid 40577897)
    • (2005) Circulation , vol.111 , Issue.16 , pp. 2033-2041
    • Woo, A.1    Williams, W.G.2    Choi, R.3    Wigle, E.D.4    Rozenblyum, E.5    Fedwick, K.6    Siu, S.7    Ralph-Edwards, A.8    Rakowski, H.9
  • 67
    • 33646186146 scopus 로고    scopus 로고
    • Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy
    • D.M. Yoerger, M.H. Picard, and I.F. Palacios Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy Am J Cardiol 97 2006 1511 1514
    • (2006) Am J Cardiol , vol.97 , pp. 1511-1514
    • Yoerger, D.M.1    Picard, M.H.2    Palacios, I.F.3
  • 71
    • 0032745561 scopus 로고    scopus 로고
    • Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy
    • I. Olivotto, B.J. Maron, and A. Montereggi Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy J Am Coll Cardiol 33 1999 2044 2051
    • (1999) J Am Coll Cardiol , vol.33 , pp. 2044-2051
    • Olivotto, I.1    Maron, B.J.2    Montereggi, A.3
  • 72
    • 0030671112 scopus 로고    scopus 로고
    • Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy
    • N. Sadoul, K. Prasad, and P.M. Elliott Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy Circulation 96 1997 2987 2991 (Pubitemid 27500099)
    • (1997) Circulation , vol.96 , Issue.9 , pp. 2987-2991
    • Sadoul, N.1    Prasad, K.2    Elliott, P.M.3    Bannerjee, S.4    Frenneaux, M.P.5    McKenna, W.J.6
  • 73
    • 0025676652 scopus 로고
    • Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy
    • M.P. Frenneaux, P.J. Counihan, and A.L. Caforio Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy Circulation 82 1990 1995 2002
    • (1990) Circulation , vol.82 , pp. 1995-2002
    • Frenneaux, M.P.1    Counihan, P.J.2    Caforio, A.L.3
  • 74
    • 2442658947 scopus 로고    scopus 로고
    • Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography
    • J.C. Moon, N.G. Fisher, and W.J. McKenna Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography Heart 90 2004 645 649 (Pubitemid 38668538)
    • (2004) Heart , vol.90 , Issue.6 , pp. 645-649
    • Moon, J.C.C.1    Fisher, N.G.2    McKenna, W.J.3    Pennell, D.J.4
  • 76
    • 55249104494 scopus 로고    scopus 로고
    • Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy
    • M.S. Maron, J.J. Finley, and J.M. Bos Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy Circulation 118 2008 1541 1549
    • (2008) Circulation , vol.118 , pp. 1541-1549
    • Maron, M.S.1    Finley, J.J.2    Bos, J.M.3
  • 77
    • 67649599134 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance
    • M.S. Maron, B.J. Maron, and C. Harrigan Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 220 228
    • (2009) J Am Coll Cardiol , vol.54 , pp. 220-228
    • Maron, M.S.1    Maron, B.J.2    Harrigan, C.3
  • 78
    • 77953118336 scopus 로고    scopus 로고
    • Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance
    • M.S. Maron, J.R. Lesser, and B.J. Maron Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance Am J Cardiol 105 2010 1842 1843
    • (2010) Am J Cardiol , vol.105 , pp. 1842-1843
    • Maron, M.S.1    Lesser, J.R.2    Maron, B.J.3
  • 80
    • 62349134146 scopus 로고    scopus 로고
    • Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy
    • M.S. Maron, E. Appelbaum, and C.J. Harrigan Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy Circ Heart Fail 1 2008 184 191
    • (2008) Circ Heart Fail , vol.1 , pp. 184-191
    • Maron, M.S.1    Appelbaum, E.2    Harrigan, C.J.3
  • 81
    • 76549083007 scopus 로고    scopus 로고
    • Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy
    • R. Rubinshtein, J.F. Glockner, and S.R. Ommen Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy Circ Heart Fail 3 2010 51 58
    • (2010) Circ Heart Fail , vol.3 , pp. 51-58
    • Rubinshtein, R.1    Glockner, J.F.2    Ommen, S.R.3
  • 82
    • 77956343217 scopus 로고    scopus 로고
    • Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy
    • R. O'Hanlon, A. Grasso, and M. Roughton Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 867 874
    • (2010) J Am Coll Cardiol , vol.56 , pp. 867-874
    • O'Hanlon, R.1    Grasso, A.2    Roughton, M.3
  • 84
    • 70349667177 scopus 로고    scopus 로고
    • Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease
    • C.A. Gange, M.S. Link, and M.S. Maron Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease Circulation 120 2009 e96 e97
    • (2009) Circulation , vol.120
    • Gange, C.A.1    Link, M.S.2    Maron, M.S.3
  • 86
    • 0344430257 scopus 로고    scopus 로고
    • Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease: Evidence for a disease specific abnormality of the myocardial interstitium
    • DOI 10.1016/j.ehj.2003.09.017
    • J.C. Moon, B. Sachdev, and A.G. Elkington Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease: evidence for a disease specific abnormality of the myocardial interstitium Eur Heart J 24 2003 2151 2155 (Pubitemid 37486535)
    • (2003) European Heart Journal , vol.24 , Issue.23 , pp. 2151-2155
    • Moon, J.C.C.1    Sachdev, B.2    Elkington, A.G.3    McKenna, W.J.4    Mehta, A.5    Pennell, D.J.6    Leed, P.J.7    Elliott, P.M.8
  • 87
    • 70349389455 scopus 로고    scopus 로고
    • ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults
    • R.F. Redberg, E.J. Benjamin, and V. Bittner ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults J Am Coll Cardiol 54 2009 1364 1405
    • (2009) J Am Coll Cardiol , vol.54 , pp. 1364-1405
    • Redberg, R.F.1    Benjamin, E.J.2    Bittner, V.3
  • 90
    • 0014880408 scopus 로고
    • Long-term propranolol therapy in muscular subaortic stenosis
    • A.G. Adelman, P.M. Shah, and R. Gramiak Long-term propranolol therapy in muscular subaortic stenosis Br Heart J 32 1970 804 811
    • (1970) Br Heart J , vol.32 , pp. 804-811
    • Adelman, A.G.1    Shah, P.M.2    Gramiak, R.3
  • 91
    • 0014082025 scopus 로고
    • Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade
    • L.S. Cohen, and E. Braunwald Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade Circulation 35 1967 847 851
    • (1967) Circulation , vol.35 , pp. 847-851
    • Cohen, L.S.1    Braunwald, E.2
  • 92
    • 0014351956 scopus 로고
    • Muscular subaortic stenosis: Prevention of outflow obstruction with propranolol
    • M.D. Flamm, D.C. Harrison, and E.W. Hancock Muscular subaortic stenosis: prevention of outflow obstruction with propranolol Circulation 38 1968 846 858
    • (1968) Circulation , vol.38 , pp. 846-858
    • Flamm, M.D.1    Harrison, D.C.2    Hancock, E.W.3
  • 93
    • 0018156084 scopus 로고
    • Long-term medical management of hypertrophic obstructive cardiomyopathy
    • M.J. Frank, A.M. Abdulla, and M.I. Canedo Long-term medical management of hypertrophic obstructive cardiomyopathy Am J Cardiol 42 1978 993 1001
    • (1978) Am J Cardiol , vol.42 , pp. 993-1001
    • Frank, M.J.1    Abdulla, A.M.2    Canedo, M.I.3
  • 94
    • 0002560471 scopus 로고
    • Effects of beta adrenergic blockade on the circulation with particular reference to observations in patients with hypertrophic subaortic stenosis
    • D.C. Harrison, E. Braunwald, and G. Glick Effects of beta adrenergic blockade on the circulation with particular reference to observations in patients with hypertrophic subaortic stenosis Circulation 29 1964 84 98
    • (1964) Circulation , vol.29 , pp. 84-98
    • Harrison, D.C.1    Braunwald, E.2    Glick, G.3
  • 95
    • 0015633004 scopus 로고
    • Hypertrophic subaortic stenosis: Clinical and hemodynamic effects of long-term propranolol therapy
    • R.E. Stenson, M.D. Flamm Jr, and D.C. Harrison Hypertrophic subaortic stenosis: clinical and hemodynamic effects of long-term propranolol therapy Am J Cardiol 31 1973 763 773
    • (1973) Am J Cardiol , vol.31 , pp. 763-773
    • Stenson, R.E.1    Flamm, Jr.M.D.2    Harrison, D.C.3
  • 97
    • 0016259257 scopus 로고
    • Medical and surgical treatment of the cardiomyopathies
    • E.D. Wigle, A.G. Adelman, and C.H. Felderhof Medical and surgical treatment of the cardiomyopathies Circ Res 35 suppl II 1974 196 207
    • (1974) Circ Res , vol.35 , Issue.SUPPL. II , pp. 196-207
    • Wigle, E.D.1    Adelman, A.G.2    Felderhof, C.H.3
  • 98
    • 0019465616 scopus 로고
    • Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy
    • R.O. Bonow, D.R. Rosing, and S.L. Bacharach Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy Circulation 64 1981 787 796 (Pubitemid 11030133)
    • (1981) Circulation , vol.64 , Issue.4 , pp. 787-796
    • Bonow, R.O.1    Rosing, D.R.2    Bacharach, S.L.3
  • 99
    • 0019452704 scopus 로고
    • Verapamil: Its potential for causing serious complications in patients with hypertrophic cardiomyopathy
    • S.E. Epstein, and D.R. Rosing Verapamil: its potential for causing serious complications in patients with hypertrophic cardiomyopathy Circulation 64 1981 437 441 (Pubitemid 11061609)
    • (1981) Circulation , vol.64 , Issue.3 , pp. 437-441
    • Epstein, S.E.1    Rosing, D.R.2
  • 100
    • 0018721067 scopus 로고
    • Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects of exercise capacity and symptomatic status
    • D.R. Rosing, K.M. Kent, and B.J. Maron Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy, II: effects on exercise capacity and symptomatic status Circulation 60 1979 1208 1213 (Pubitemid 10215863)
    • (1979) Circulation , vol.60 , Issue.6 , pp. 1208-1213
    • Rosing, D.R.1    Kent, K.M.2    Maron, B.J.3    Epstein, S.E.4
  • 101
    • 0018677177 scopus 로고
    • Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects
    • D.R. Rosing, K.M. Kent, and J.S. Borer Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy, I: hemodynamic effects Circulation 60 1979 1201 1207 (Pubitemid 10215862)
    • (1979) Circulation , vol.60 , Issue.6 , pp. 1201-1207
    • Rosing, D.R.1    Kent, K.M.2    Borer, J.S.3
  • 102
    • 0019414136 scopus 로고
    • Verapamil therapy: A new approach to the pharmacologic treatment of hypertrophic cardiomyopathy: III. Effects of long-term administration
    • DOI 10.1016/0002-9149(81)90086-2
    • D.R. Rosing, J.R. Condit, and B.J. Maron Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy, III: effects of long-term administration Am J Cardiol 48 1981 545 553 (Pubitemid 11014401)
    • (1981) American Journal of Cardiology , vol.48 , Issue.3 , pp. 545-553
    • Rosing, C.R.1    Condit, J.R.2    Maron, B.J.3
  • 103
    • 0000861028 scopus 로고
    • Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs
    • E. Braunwald, and P.A. Ebert Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs Am J Cardiol 10 1962 489 495
    • (1962) Am J Cardiol , vol.10 , pp. 489-495
    • Braunwald, E.1    Ebert, P.A.2
  • 104
    • 44049085110 scopus 로고
    • Muscular subaortic stenosis: The interrelation of wall tension, outflow tract "distending pressure" and orifice radius
    • E.D. Wigle, P.R. David, and C.J. Labroose Muscular subaortic stenosis: the interrelation of wall tension, outflow tract "distending pressure" and orifice radius Am J Cardiol 15 1965 761 772
    • (1965) Am J Cardiol , vol.15 , pp. 761-772
    • Wigle, E.D.1    David, P.R.2    Labroose, C.J.3
  • 105
    • 0032848154 scopus 로고    scopus 로고
    • Dynamic left ventricular outflow tract obstruction in acute coronary syndromes: An important cause of new systolic murmur and cardiogenic shock
    • J.H. Haley, L.J. Sinak, and A.J. Tajik Dynamic left ventricular outflow tract obstruction in acute coronary syndromes: an important cause of new systolic murmur and cardiogenic shock Mayo Clin Proc 74 1999 901 906 (Pubitemid 29430359)
    • (1999) Mayo Clinic Proceedings , vol.74 , Issue.9 , pp. 901-906
    • Haley, J.H.1    Sinak M, L.J.2    Jamil Tajik, A.3    Ommen, S.R.4    Jae, K.O.H.5
  • 106
    • 0027318313 scopus 로고
    • Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy
    • DOI 10.1016/0002-8703(93)90760-7
    • B.P. Kimball, S. Bui, and E.D. Wigle Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy Am Heart J 125 1993 1691 1697 (Pubitemid 23169485)
    • (1993) American Heart Journal , vol.125 , Issue.6 , pp. 1691-1697
    • Kimball, B.P.1    Bui, S.2    Wigle, E.D.3
  • 107
    • 0023812613 scopus 로고
    • Disopyramide in hypertrophic cardiomyopathy, I: Hemodynamic assessment after intravenous administration
    • C. Pollick, B. Kimball, and M. Henderson Disopyramide in hypertrophic cardiomyopathy, I: hemodynamic assessment after intravenous administration Am J Cardiol 62 1988 1248 1251
    • (1988) Am J Cardiol , vol.62 , pp. 1248-1251
    • Pollick, C.1    Kimball, B.2    Henderson, M.3
  • 108
    • 0023756911 scopus 로고
    • Disopyramide in hypertrophic cardiomyopathy, II: Noninvasive assessment after oral administration
    • C. Pollick Disopyramide in hypertrophic cardiomyopathy, II: noninvasive assessment after oral administration Am J Cardiol 62 1988 1252 1255
    • (1988) Am J Cardiol , vol.62 , pp. 1252-1255
    • Pollick, C.1
  • 109
    • 0023699943 scopus 로고
    • Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy
    • DOI 10.1016/0002-9149(88)90553-X
    • M. Sherrid, E. Delia, and E. Dwyer Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy Am J Cardiol 62 1988 1085 1088 (Pubitemid 18267570)
    • (1988) American Journal of Cardiology , vol.62 , Issue.16 , pp. 1085-1088
    • Sherrid, M.1    Delia, E.2    Dwyer, E.3
  • 110
    • 0002825293 scopus 로고
    • Studies on digitalis, IV: Observation in man on the effects of digitalis preparations on the contractility of the non-failing heart and on total vascular resistance
    • E. Braunwald, R.D. Bloodwell, and L.I. Goldberg Studies on digitalis, IV: observation in man on the effects of digitalis preparations on the contractility of the non-failing heart and on total vascular resistance J Clin Invest 40 1961 52 59
    • (1961) J Clin Invest , vol.40 , pp. 52-59
    • Braunwald, E.1    Bloodwell, R.D.2    Goldberg, L.I.3
  • 111
    • 33847594134 scopus 로고
    • Studies on digitalis, V: Comparison of the effects of ouabain on left ventricular dynamics in valvular aortic stenosis and hypertrophic subaortic stenosis
    • E. Braunwald, E.C. Brockenbrough, and R.L. Frye Studies on digitalis, V: comparison of the effects of ouabain on left ventricular dynamics in valvular aortic stenosis and hypertrophic subaortic stenosis Circulation 26 1962 166 173
    • (1962) Circulation , vol.26 , pp. 166-173
    • Braunwald, E.1    Brockenbrough, E.C.2    Frye, R.L.3
  • 112
    • 0013950647 scopus 로고
    • Studies on digitalis, XV: Effects of cardiac glycosides on myocardial force-velocity relations in the nonfailing human heart
    • E.H. Sonnenblick, J.F. Williams Jr, and G. Glick Studies on digitalis, XV: effects of cardiac glycosides on myocardial force-velocity relations in the nonfailing human heart Circulation 34 1966 532 539
    • (1966) Circulation , vol.34 , pp. 532-539
    • Sonnenblick, E.H.1    Williams, Jr.J.F.2    Glick, G.3
  • 113
    • 0026539646 scopus 로고
    • Comparative class 1 electrophysiologic and anticholinergic effects of disopyramide and its main metabolite (mono-N-dealkylated disopyramide) in healthy humans
    • L. Bergfeldt, K. Schenck-Gustafsson, and R. Dahlqvist Comparative class 1 electrophysiologic and anticholinergic effects of disopyramide and its main metabolite (mono-N-dealkylated disopyramide) in healthy humans Cardiovasc Drugs Ther 6 1992 529 537
    • (1992) Cardiovasc Drugs Ther , vol.6 , pp. 529-537
    • Bergfeldt, L.1    Schenck-Gustafsson, K.2    Dahlqvist, R.3
  • 114
    • 0017700919 scopus 로고
    • Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods
    • J.S. Birkhead, and E.M. Vaughan Williams Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods Br Heart J 39 1977 657 660 (Pubitemid 8180743)
    • (1977) British Heart Journal , vol.39 , Issue.6 , pp. 657-660
    • Birkhead, J.S.1    Vaughan Williams, E.M.2
  • 115
    • 0017236176 scopus 로고
    • Circulatory effects of intravenous disopyramide in heart failure
    • G. Jensen, and A. Uhrenholt Circulatory effects of intravenous disopyramide in heart failure J Int Med Res 4 1976 42 45
    • (1976) J Int Med Res , vol.4 , pp. 42-45
    • Jensen, G.1    Uhrenholt, A.2
  • 116
    • 0019154576 scopus 로고
    • Potentially dangerous effect of disopyramide on atrioventricular conduction in a patient on digitalis
    • M. Lara, G.D. Oakley, and D. Rowbotham Potentially dangerous effect of disopyramide on atrioventricular conduction in a patient on digitalis Br Med J 281 1980 198 (Pubitemid 10073438)
    • (1980) British Medical Journal , vol.281 , Issue.6234 , pp. 198
    • Lara, M.1    Oakley, G.D.G.2    Rowbotham, D.3
  • 118
    • 0019129795 scopus 로고
    • Extreme tachycardia complicating the use of disopyramide in atrial flutter
    • C.E. Robertson, and H.C. Miller Extreme tachycardia complicating the use of disopyramide in atrial flutter Br Heart J 44 1980 602 603 (Pubitemid 11217148)
    • (1980) British Heart Journal , vol.44 , Issue.5 , pp. 602-603
    • Robertson, C.E.1    Miller, H.C.2
  • 119
  • 120
    • 0041509774 scopus 로고
    • Reversible obstruction of the ventricular outflow tract
    • N. Krasnow, E. Rolett, and W.B.J. Hood Reversible obstruction of the ventricular outflow tract Am J Cardiol 11 1963 1 7
    • (1963) Am J Cardiol , vol.11 , pp. 1-7
    • Krasnow, N.1    Rolett, E.2    Hood, W.B.J.3
  • 121
    • 0345625077 scopus 로고
    • Idiopathic hypertrophic subaortic stenosis, 3: Intraoperative studies of the mechanism of obstruction and its hemodynamic consequences
    • G.E. Pierce, A.G. Morrow, and E. Braunwald Idiopathic hypertrophic subaortic stenosis, 3: intraoperative studies of the mechanism of obstruction and its hemodynamic consequences Circulation 30 suppl 4 1964 152
    • (1964) Circulation , vol.30 , Issue.SUPPL. 4 , pp. 152
    • Pierce, G.E.1    Morrow, A.G.2    Braunwald, E.3
  • 122
    • 50549173847 scopus 로고
    • Demonstration of the dynamic nature of idiopathic hypertrophic subaortic stenosis
    • R.E. Whalen, A.I. Cohen, and R.G. Sumner Demonstration of the dynamic nature of idiopathic hypertrophic subaortic stenosis Am J Cardiol 11 1963 8 17
    • (1963) Am J Cardiol , vol.11 , pp. 8-17
    • Whalen, R.E.1    Cohen, A.I.2    Sumner, R.G.3
  • 123
    • 43049161330 scopus 로고    scopus 로고
    • Usefulness of clinical, echocardiographic, and procedural characteristics to predict outcome after percutaneous transluminal septal myocardial ablation
    • C. van der Lee, B. Scholzel, and J.M. ten Berg Usefulness of clinical, echocardiographic, and procedural characteristics to predict outcome after percutaneous transluminal septal myocardial ablation Am J Cardiol 101 2008 1315 1320
    • (2008) Am J Cardiol , vol.101 , pp. 1315-1320
    • Van Der Lee, C.1    Scholzel, B.2    Ten Berg, J.M.3
  • 124
    • 0036800523 scopus 로고    scopus 로고
    • Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy: A comparison of clinical, haemodynamic and exercise outcomes
    • DOI 10.1053/euhj.2002.3285
    • S. Firoozi, P.M. Elliott, and S. Sharma Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy: a comparison of clinical, haemodynamic and exercise outcomes Eur Heart J 23 2002 1617 1624 (Pubitemid 35221567)
    • (2002) European Heart Journal , vol.23 , Issue.20 , pp. 1617-1624
    • Firoozi, S.1    Elliott, P.M.2    Sharma, S.3    Murday, A.4    Brecker, S.J.5    Hamid, M.S.6    Sachdev, B.7    Thaman, R.8    McKenna, W.J.9
  • 127
    • 0030475235 scopus 로고    scopus 로고
    • Hypertrophic obstructive cardiomyopathy in pediatric patients: Results of surgical treatment
    • D.A. Theodoro, G.K. Danielson, and R.H. Feldt Hypertrophic obstructive cardiomyopathy in pediatric patients: results of surgical treatment J Thorac Cardiovasc Surg 112 1996 1589 1597
    • (1996) J Thorac Cardiovasc Surg , vol.112 , pp. 1589-1597
    • Theodoro, D.A.1    Danielson, G.K.2    Feldt, R.H.3
  • 128
    • 2442671478 scopus 로고    scopus 로고
    • Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: Feasibility, clinical benefit, and short term results in elderly patients
    • F.H. Gietzen, C.J. Leuner, and L. Obergassel Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients Heart 90 2004 638 644 (Pubitemid 38668537)
    • (2004) Heart , vol.90 , Issue.6 , pp. 638-644
    • Gietzen, F.H.1    Leuner, C.J.2    Obergassel, L.3    Strunk-Mueller, C.4    Kuhn, H.5
  • 130
    • 49449110234 scopus 로고    scopus 로고
    • Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation
    • D.H. Kwon, S.R. Kapadia, and E.M. Tuzcu Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation JACC Cardiovasc Interv 1 2008 432 438
    • (2008) JACC Cardiovasc Interv , vol.1 , pp. 432-438
    • Kwon, D.H.1    Kapadia, S.R.2    Tuzcu, E.M.3
  • 133
    • 0033950642 scopus 로고    scopus 로고
    • Dual chamber pacing for patients with hypertrophic obstructive cardiomyopathy: A clinical perspective in 2000
    • J.P. Erwin III, R.A. Nishimura, and M.A. Lloyd Dual chamber pacing for patients with hypertrophic obstructive cardiomyopathy: a clinical perspective in 2000 Mayo Clin Proc 75 2000 173 180 (Pubitemid 30080708)
    • (2000) Mayo Clinic Proceedings , vol.75 , Issue.2 , pp. 173-180
    • Erwin III, J.P.1    Nishimura, R.A.2    Lloyd, M.A.3    Tajik, A.J.4
  • 134
  • 136
    • 0033165555 scopus 로고    scopus 로고
    • Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: A comparison of objective hemodynamic and exercise end points
    • S.R. Ommen, R.A. Nishimura, and R.W. Squires Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise end points J Am Coll Cardiol 34 1999 191 196
    • (1999) J Am Coll Cardiol , vol.34 , pp. 191-196
    • Ommen, S.R.1    Nishimura, R.A.2    Squires, R.W.3
  • 137
    • 0033536029 scopus 로고    scopus 로고
    • Assessment of permanent dual-chamber pacing as a treatment for drug- refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: A randomized, double-blind, crossover study (M-PATHY)
    • B.J. Maron, R.A. Nishimura, and W.J. McKenna Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind, crossover study (M-PATHY) Circulation 99 1999 2927 2933 (Pubitemid 29258982)
    • (1999) Circulation , vol.99 , Issue.22 , pp. 2927-2933
    • Maron, B.J.1    Nishimura, R.A.2    McKenna, W.J.3    Rakowski, H.4    Josephson, M.E.5    Kieval, R.S.6
  • 140
    • 0032103098 scopus 로고    scopus 로고
    • Implications of left ventricular remodeling in hypertrophic cardiomyopathy
    • DOI 10.1016/S0002-9149(98)00164-7, PII S0002914998001647
    • B.J. Maron, and P. Spirito Implications of left ventricular remodeling in hypertrophic cardiomyopathy Am J Cardiol 81 1998 1339 1344 (Pubitemid 28268673)
    • (1998) American Journal of Cardiology , vol.81 , Issue.11 , pp. 1339-1344
    • Maron, B.J.1    Spirito, P.2
  • 142
    • 70450221509 scopus 로고    scopus 로고
    • Outcomes of pediatric patients with hypertrophic cardiomyopathy listed for transplant
    • R. Gajarski, D.C. Naftel, and E. Pahl Outcomes of pediatric patients with hypertrophic cardiomyopathy listed for transplant J Heart Lung Transplant 28 2009 1329 1334
    • (2009) J Heart Lung Transplant , vol.28 , pp. 1329-1334
    • Gajarski, R.1    Naftel, D.C.2    Pahl, E.3
  • 143
    • 0036109734 scopus 로고    scopus 로고
    • Cardiomyopathy and heart transplantation in children
    • DOI 10.1097/00001573-200205000-00011
    • J.A. Towbin Cardiomyopathy and heart transplantation in children Curr Opin Cardiol 17 2002 274 279 (Pubitemid 34553633)
    • (2002) Current Opinion in Cardiology , vol.17 , Issue.3 , pp. 274-279
    • Towbin, J.A.1
  • 144
    • 78349293794 scopus 로고    scopus 로고
    • Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy
    • B.J. Maron Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy Circ J 74 2010 2271 2282
    • (2010) Circ J , vol.74 , pp. 2271-2282
    • Maron, B.J.1
  • 145
    • 76649106709 scopus 로고    scopus 로고
    • Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy
    • B.J. Maron Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy Circulation 121 2010 445 456
    • (2010) Circulation , vol.121 , pp. 445-456
    • Maron, B.J.1
  • 146
    • 0024605645 scopus 로고
    • Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest
    • F. Cecchi, B.J. Maron, and S.E. Epstein Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest J Am Coll Cardiol 13 1989 1283 1288 (Pubitemid 19114200)
    • (1989) Journal of the American College of Cardiology , vol.13 , Issue.6 , pp. 1283-1288
    • Cecchi, F.1    Maron, B.J.2    Epstein, S.E.3
  • 147
    • 0033133591 scopus 로고    scopus 로고
    • Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy
    • P.M. Elliott, S. Sharma, and A. Varnava Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 33 1999 1596 1601
    • (1999) J Am Coll Cardiol , vol.33 , pp. 1596-1601
    • Elliott, P.M.1    Sharma, S.2    Varnava, A.3
  • 148
    • 0033667442 scopus 로고    scopus 로고
    • Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients
    • P.M. Elliott, J. Poloniecki, and S. Dickie Sudden death in hypertrophic cardiomyopathy: identification of high risk patients J Am Coll Cardiol 36 2000 2212 2218
    • (2000) J Am Coll Cardiol , vol.36 , pp. 2212-2218
    • Elliott, P.M.1    Poloniecki, J.2    Dickie, S.3
  • 149
    • 0026788083 scopus 로고
    • Prognostic determinants in hypertrophic cardiomyopathy: Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings
    • L. Fananapazir, A.C. Chang, and S.E. Epstein Prognostic determinants in hypertrophic cardiomyopathy: prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings Circulation 86 1992 730 740
    • (1992) Circulation , vol.86 , pp. 730-740
    • Fananapazir, L.1    Chang, A.C.2    Epstein, S.E.3
  • 150
    • 0032530590 scopus 로고    scopus 로고
    • Predictors of sudden cardiac death in hypertrophic cardiomyopathy
    • S. Maki, H. Ikeda, and A. Muro Predictors of sudden cardiac death in hypertrophic cardiomyopathy Am J Cardiol 82 1998 774 778
    • (1998) Am J Cardiol , vol.82 , pp. 774-778
    • Maki, S.1    Ikeda, H.2    Muro, A.3
  • 152
    • 0019458147 scopus 로고
    • Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features
    • DOI 10.1016/0002-9149(81)90535-X
    • W. McKenna, J. Deanfield, and A. Faruqui Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features Am J Cardiol 47 1981 532 538 (Pubitemid 11137648)
    • (1981) American Journal of Cardiology , vol.47 , Issue.3 , pp. 532-538
    • McKenna, W.1    Deanfield, J.2    Faruqui, A.3
  • 153
    • 65349127673 scopus 로고    scopus 로고
    • Syncope and risk of sudden death in hypertrophic cardiomyopathy
    • P. Spirito, C. Autore, and C. Rapezzi Syncope and risk of sudden death in hypertrophic cardiomyopathy Circulation 119 2009 1703 1710
    • (2009) Circulation , vol.119 , pp. 1703-1710
    • Spirito, P.1    Autore, C.2    Rapezzi, C.3
  • 155
    • 52149115094 scopus 로고    scopus 로고
    • Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy
    • B.J. Maron, and P. Spirito Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy J Cardiovasc Electrophysiol 19 2008 1118 1126
    • (2008) J Cardiovasc Electrophysiol , vol.19 , pp. 1118-1126
    • Maron, B.J.1    Spirito, P.2
  • 156
    • 78149444773 scopus 로고    scopus 로고
    • Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy
    • J.M. Bos, B.J. Maron, and M.J. Ackerman Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy Am J Cardiol 106 2010 1481 1486
    • (2010) Am J Cardiol , vol.106 , pp. 1481-1486
    • Bos, J.M.1    Maron, B.J.2    Ackerman, M.J.3
  • 157
    • 0035835456 scopus 로고    scopus 로고
    • Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy
    • DOI 10.1016/S0140-6736(00)04005-8
    • P.M. Elliott, J.R. Gimeno Blanes, and N.G. Mahon Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy Lancet 357 2001 420 424 (Pubitemid 32156140)
    • (2001) Lancet , vol.357 , Issue.9254 , pp. 420-424
    • Elliott, P.M.1    Gimeno Blanes, J.R.2    Mahon, N.G.3    Poloniecki, J.D.4    McKenna, W.J.5
  • 160
    • 13444249202 scopus 로고    scopus 로고
    • Prevention of sudden death in hypertrophic cardiomyopathy: But which defibrillator for which patient?
    • G. Boriani, B.J. Maron, and W.K. Shen Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient? Circulation 110 2004 e438 e442
    • (2004) Circulation , vol.110
    • Boriani, G.1    Maron, B.J.2    Shen, W.K.3
  • 161
    • 57149137652 scopus 로고    scopus 로고
    • Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients
    • R.G. Hauser, B.J. Maron, and J.E. Marine Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients Heart Rhythm 5 2008 1517 1522
    • (2008) Heart Rhythm , vol.5 , pp. 1517-1522
    • Hauser, R.G.1    Maron, B.J.2    Marine, J.E.3
  • 162
    • 34248579318 scopus 로고    scopus 로고
    • Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years
    • DOI 10.1161/CIRCULATIONAHA.106.663807
    • T. Kleemann, T. Becker, and K. Doenges Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years Circulation 115 2007 2474 2480 (Pubitemid 46763220)
    • (2007) Circulation , vol.115 , Issue.19 , pp. 2474-2480
    • Kleemann, T.1    Becker, T.2    Doenges, K.3    Vater, M.4    Senges, J.5    Schneider, S.6    Saggau, W.7    Weisse, U.8    Seidl, K.9
  • 165
    • 24144462322 scopus 로고    scopus 로고
    • Recommendations for competitive sports participation in athletes with cardiovascular disease: A consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology
    • A. Pelliccia, R. Fagard, and H.H. Bjornstad Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology Eur Heart J 26 2005 1422 1445
    • (2005) Eur Heart J , vol.26 , pp. 1422-1445
    • Pelliccia, A.1    Fagard, R.2    Bjornstad, H.H.3
  • 167
    • 0042734704 scopus 로고    scopus 로고
    • Sudden death in young athletes
    • DOI 10.1056/NEJMra022783
    • B.J. Maron Sudden death in young athletes N Engl J Med 349 2003 1064 1075 (Pubitemid 37098275)
    • (2003) New England Journal of Medicine , vol.349 , Issue.11 , pp. 1064-1075
    • Maron, B.J.1
  • 169
    • 62649113485 scopus 로고    scopus 로고
    • Sudden deaths in young competitive athletes: Analysis of 1866 deaths in the United States, 19802006
    • B.J. Maron, J.J. Doerer, and T.S. Haas Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 19802006 Circulation 119 2009 1085 1092
    • (2009) Circulation , vol.119 , pp. 1085-1092
    • Maron, B.J.1    Doerer, J.J.2    Haas, T.S.3
  • 171
    • 79953038399 scopus 로고    scopus 로고
    • 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation
    • V. Fuster, L.E. Ryden, and D.S. Cannom 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation Circulation 123 2011 e269 e367
    • (2011) Circulation , vol.123
    • Fuster, V.1    Ryden, L.E.2    Cannom, D.S.3
  • 173
    • 0035923562 scopus 로고    scopus 로고
    • Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy
    • I. Olivotto, F. Cecchi, and S.A. Casey Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy Circulation 104 2001 2517 2524 (Pubitemid 33107372)
    • (2001) Circulation , vol.104 , Issue.21 , pp. 2517-2524
    • Olivotto, I.1    Cecchi, F.2    Casey, S.A.3    Dolara, A.4    Traverse, J.H.5    Maron, B.J.6
  • 174
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
    • (2009) N Engl J Med , vol.361 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3
  • 175
    • 0027161276 scopus 로고
    • Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy
    • M. Tendera, A. Wycisk, and A. Schneeweiss Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy Cardiology 82 1993 335 342 (Pubitemid 23245975)
    • (1993) Cardiology , vol.82 , Issue.5 , pp. 335-342
    • Tendera, M.1    Wycisk, A.2    Schneeweiss, A.3    Polonski, L.4    Wodniecki, J.5
  • 176
    • 52049100334 scopus 로고    scopus 로고
    • Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
    • T.J. Bunch, T.M. Munger, and P.A. Friedman Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy J Cardiovasc Electrophysiol 19 2008 1009 1014
    • (2008) J Cardiovasc Electrophysiol , vol.19 , pp. 1009-1014
    • Bunch, T.J.1    Munger, T.M.2    Friedman, P.A.3
  • 177
    • 52049083649 scopus 로고    scopus 로고
    • Ablation of atrial fibrillation in the setting of hypertrophic cardiomyopathy
    • D.J. Callans Ablation of atrial fibrillation in the setting of hypertrophic cardiomyopathy J Cardiovasc Electrophysiol 19 2008 1015 1016
    • (2008) J Cardiovasc Electrophysiol , vol.19 , pp. 1015-1016
    • Callans, D.J.1
  • 178
    • 77749333435 scopus 로고    scopus 로고
    • Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: Impact of age, atrial remodelling, and disease progression
    • P. Di Donna, I. Olivotto, and S.D. Delcre Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression Europace 12 2010 347 355
    • (2010) Europace , vol.12 , pp. 347-355
    • Di Donna, P.1    Olivotto, I.2    Delcre, S.D.3
  • 182
    • 77952305563 scopus 로고    scopus 로고
    • Parental knowledge and attitudes toward hypertrophic cardiomyopathy genetic testing
    • S.M. Fitzgerald-Butt, L. Byrne, and C.A. Gerhardt Parental knowledge and attitudes toward hypertrophic cardiomyopathy genetic testing Pediatr Cardiol 31 2010 195 202
    • (2010) Pediatr Cardiol , vol.31 , pp. 195-202
    • Fitzgerald-Butt, S.M.1    Byrne, L.2    Gerhardt, C.A.3
  • 183
    • 0347989434 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy: An important global disease
    • DOI 10.1016/j.amjmed.2003.10.012
    • B.J. Maron Hypertrophic cardiomyopathy: an important global disease Am J Med 116 2004 63 65 (Pubitemid 38050032)
    • (2004) American Journal of Medicine , vol.116 , Issue.1 , pp. 63-65
    • Maron, B.J.1
  • 185
    • 0029083650 scopus 로고
    • Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA Study Coronary Artery Risk Development in (Young) Adults
    • B.J. Maron, J.M. Gardin, and J.M. Flack Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study Coronary Artery Risk Development in (Young) Adults Circulation 92 1995 785 789
    • (1995) Circulation , vol.92 , pp. 785-789
    • Maron, B.J.1    Gardin, J.M.2    Flack, J.M.3
  • 186
    • 0018488057 scopus 로고
    • Hypertrophic cardiomyopathy: A discussion of nomenclature
    • B.J. Maron, and S.E. Epstein Hypertrophic cardiomyopathy: a discussion of nomenclature Am J Cardiol 43 1979 1242 1244
    • (1979) Am J Cardiol , vol.43 , pp. 1242-1244
    • Maron, B.J.1    Epstein, S.E.2
  • 187
    • 33646693410 scopus 로고    scopus 로고
    • Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention
    • DOI 10.1161/CIRCULATIONAHA.106.174287, PII 0000301720060411000015
    • B.J. Maron, J.A. Towbin, and G. Thiene Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 113 2006 1807 1816 (Pubitemid 43958474)
    • (2006) Circulation , vol.113 , Issue.14 , pp. 1807-1816
    • Maron, B.J.1    Towbin, J.A.2    Thiene, G.3    Antzelevitch, C.4    Corrado, D.5    Arnett, D.6    Moss, A.J.7    Seidman, C.E.8    Young, J.B.9
  • 188
    • 77449148896 scopus 로고    scopus 로고
    • How should hypertrophic cardiomyopathy be classified What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy
    • B.J. Maron, C.E. Seidman, and M.J. Ackerman How should hypertrophic cardiomyopathy be classified What's in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy Circ Cardiovasc Genet 2 2009 81 85
    • (2009) Circ Cardiovasc Genet , vol.2 , pp. 81-85
    • Maron, B.J.1    Seidman, C.E.2    Ackerman, M.J.3
  • 189
    • 79551682679 scopus 로고    scopus 로고
    • Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy
    • B.J. Maron, L. Yeates, and C. Semsarian Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy Am J Cardiol 107 2011 604 608
    • (2011) Am J Cardiol , vol.107 , pp. 604-608
    • Maron, B.J.1    Yeates, L.2    Semsarian, C.3
  • 190
    • 77954348119 scopus 로고    scopus 로고
    • Emergence of gene mutation carriers and the expanding disease spectrum of hypertrophic cardiomyopathy
    • B.J. Maron, and C. Semsarian Emergence of gene mutation carriers and the expanding disease spectrum of hypertrophic cardiomyopathy Eur Heart J 31 2010 1551 1553
    • (2010) Eur Heart J , vol.31 , pp. 1551-1553
    • Maron, B.J.1    Semsarian, C.2
  • 191
    • 0019442765 scopus 로고
    • Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients
    • DOI 10.1016/0002-9149(81)90068-0
    • B.J. Maron, J.S. Gottdiener, and S.E. Epstein Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two dimensional echocardiographic study of 125 patients Am J Cardiol 48 1981 418 428 (Pubitemid 11014383)
    • (1981) American Journal of Cardiology , vol.48 , Issue.3 , pp. 418-428
    • Maron, B.J.1    Gottdiener, J.S.2    Epstein, S.E.3
  • 192
    • 0028927735 scopus 로고
    • Cardiac disease in young trained athletes: Insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy
    • B.J. Maron, A. Pelliccia, and P. Spirito Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy Circulation 91 1995 1596 1601
    • (1995) Circulation , vol.91 , pp. 1596-1601
    • Maron, B.J.1    Pelliccia, A.2    Spirito, P.3
  • 193
    • 33749637506 scopus 로고    scopus 로고
    • The heart of trained athletes: Cardiac remodeling and the risks of sports, including sudden death
    • DOI 10.1161/CIRCULATIONAHA.106.613562, PII 0000301720061010000014
    • B.J. Maron, and A. Pelliccia The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death Circulation 114 2006 1633 1644 (Pubitemid 44547434)
    • (2006) Circulation , vol.114 , Issue.15 , pp. 1633-1644
    • Maron, B.J.1    Pelliccia, A.2
  • 194
    • 69949142200 scopus 로고    scopus 로고
    • Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: Clinical significance, diagnostic strategies and implications for preparticipation screening
    • B.J. Maron Distinguishing hypertrophic cardiomyopathy from athlete's heart physiological remodelling: clinical significance, diagnostic strategies and implications for preparticipation screening Br J Sports Med 43 2009 649 656
    • (2009) Br J Sports Med , vol.43 , pp. 649-656
    • Maron, B.J.1
  • 195
    • 77950315466 scopus 로고    scopus 로고
    • Long-term clinical consequences of intense, uninterrupted endurance training in Olympic athletes
    • A. Pelliccia, N. Kinoshita, and C. Pisicchio Long-term clinical consequences of intense, uninterrupted endurance training in Olympic athletes J Am Coll Cardiol 55 2010 1619 1625
    • (2010) J Am Coll Cardiol , vol.55 , pp. 1619-1625
    • Pelliccia, A.1    Kinoshita, N.2    Pisicchio, C.3
  • 196
    • 77955982419 scopus 로고    scopus 로고
    • Prevalence and clinical significance of aortic root dilation in highly trained competitive athletes
    • 3
    • A. Pelliccia, F.M. Di Paolo, and E. De Blasiis Prevalence and clinical significance of aortic root dilation in highly trained competitive athletes Circulation 122 2010 698 706 3
    • (2010) Circulation , vol.122 , pp. 698-706
    • Pelliccia, A.1    Di Paolo, F.M.2    De Blasiis, E.3
  • 200
    • 37549040201 scopus 로고    scopus 로고
    • Genetic basis of hypertrophic cardiomyopathy: From bench to the clinics
    • R. Alcalai, J.G. Seidman, and C.E. Seidman Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics J Cardiovasc Electrophysiol 19 2008 104 110
    • (2008) J Cardiovasc Electrophysiol , vol.19 , pp. 104-110
    • Alcalai, R.1    Seidman, J.G.2    Seidman, C.E.3
  • 201
    • 63349109161 scopus 로고    scopus 로고
    • Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy
    • B.J. Maron, W.C. Roberts, and M. Arad Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy JAMA 301 2009 1253 1259
    • (2009) JAMA , vol.301 , pp. 1253-1259
    • Maron, B.J.1    Roberts, W.C.2    Arad, M.3
  • 203
    • 33847103768 scopus 로고    scopus 로고
    • Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: Findings from the Pediatric Cardiomyopathy Registry
    • DOI 10.1161/CIRCULATIONAHA.106.621185, PII 0000301720070213000015
    • S.D. Colan, S.E. Lipshultz, and A.M. Lowe Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry Circulation 115 2007 773 781 (Pubitemid 46294745)
    • (2007) Circulation , vol.115 , Issue.6 , pp. 773-781
    • Colan, S.D.1    Lipshultz, S.E.2    Lowe, A.M.3    Sleeper, L.A.4    Messere, J.5    Cox, G.F.6    Lurie, P.R.7    Orav, E.J.8    Towbin, J.A.9
  • 204
    • 33749003166 scopus 로고    scopus 로고
    • Noonan syndrome and related disorders: Dysregulated RAS-mitogen activated protein kinase signal transduction
    • B.D. Gelb, and M. Tartaglia Noonan syndrome and related disorders: dysregulated RAS-mitogen activated protein kinase signal transduction Hum Mol Genet 15 Spec No 2 2006 R220 R226
    • (2006) Hum Mol Genet , vol.152 SPEC NO
    • Gelb, B.D.1    Tartaglia, M.2
  • 209
    • 0035936792 scopus 로고    scopus 로고
    • The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms
    • DOI 10.1016/S0092-8674(01)00242-2
    • J.G. Seidman, and C. Seidman The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms Cell 104 2001 557 567 (Pubitemid 32201950)
    • (2001) Cell , vol.104 , Issue.4 , pp. 557-567
    • Seidman, J.G.1    Seidman, C.2
  • 210
    • 70349509053 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy centers
    • B.J. Maron Hypertrophic cardiomyopathy centers Am J Cardiol 104 2009 1158 1159
    • (2009) Am J Cardiol , vol.104 , pp. 1158-1159
    • Maron, B.J.1
  • 211
    • 39449122818 scopus 로고    scopus 로고
    • Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy
    • DOI 10.1097/GIM.0b013e3181612cc7, PII 0012581720080200000007
    • J. Ingles, J.M. Lind, and P. Phongsavan Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy Genet Med 10 2008 117 120 (Pubitemid 351271723)
    • (2008) Genetics in Medicine , vol.10 , Issue.2 , pp. 117-120
    • Ingles, J.1    Lind, J.M.2    Phongsavan, P.3    Semsarian, C.4
  • 212
    • 0028824221 scopus 로고
    • Natural history of hypertrophic cardiomyopathy: A population-based study, 1976 through 1990
    • C.R. Cannan, G.S. Reeder, and K.R. Bailey Natural history of hypertrophic cardiomyopathy: a population-based study, 1976 through 1990 Circulation 92 1995 2488 2495
    • (1995) Circulation , vol.92 , pp. 2488-2495
    • Cannan, C.R.1    Reeder, G.S.2    Bailey, K.R.3
  • 213
    • 0028818347 scopus 로고
    • Hypertrophic cardiomyopathy in Tuscany: Clinical course and outcome in an unselected regional population
    • F. Cecchi, I. Olivotto, and A. Montereggi Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population J Am Coll Cardiol 26 1995 1529 1536
    • (1995) J Am Coll Cardiol , vol.26 , pp. 1529-1536
    • Cecchi, F.1    Olivotto, I.2    Montereggi, A.3
  • 216
    • 64649085794 scopus 로고    scopus 로고
    • Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy
    • B.J. Maron, C. Semsarian, and W.K. Shen Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy Heart Rhythm 6 2009 599 602
    • (2009) Heart Rhythm , vol.6 , pp. 599-602
    • Maron, B.J.1    Semsarian, C.2    Shen, W.K.3
  • 217
    • 0000745274 scopus 로고
    • Functional obstruction of the left ventricle; Acquired aortic subvalvar stenosis
    • R. Brock Functional obstruction of the left ventricle; acquired aortic subvalvar stenosis Guys Hosp Rep 106 1957 221 238
    • (1957) Guys Hosp Rep , vol.106 , pp. 221-238
    • Brock, R.1
  • 218
    • 0022372741 scopus 로고
    • Has 'obstruction' hindered our understanding of hypertrophic cardiomyopathy?
    • J.M. Criley, and R.J. Siegel Has "obstruction" hindered our understanding of hypertrophic cardiomyopathy? Circulation 72 1985 1148 1154 (Pubitemid 16126793)
    • (1985) Circulation , vol.72 , Issue.6 , pp. 1148-1154
    • Criley, J.M.1    Siegel, R.J.2
  • 219
    • 0022447497 scopus 로고
    • Obstruction is unimportant in the pathophysiology of hypertrophic cardiomyopathy
    • J.M. Criley, and R.J. Siegel Obstruction is unimportant in the pathophysiology of hypertrophic cardiomyopathy Postgrad Med J 62 1986 515 529 (Pubitemid 16038693)
    • (1986) Postgraduate Medical Journal , vol.62 , Issue.728 , pp. 515-529
    • Criley, J.M.1    Siegel, R.J.2
  • 220
    • 0030935188 scopus 로고    scopus 로고
    • Unobstructed thinking (and terminology) is called for in the understanding and management of hypertrophic cardiomyopathy
    • DOI 10.1016/S0735-1097(96)00590-6, PII S0735109796005906
    • J.M. Criley Unobstructed thinking (and terminology) is called for in the understanding and management of hypertrophic cardiomyopathy J Am Coll Cardiol 29 1997 741 743 (Pubitemid 27128245)
    • (1997) Journal of the American College of Cardiology , vol.29 , Issue.4 , pp. 741-743
    • Criley, J.M.1
  • 221
    • 67649628989 scopus 로고    scopus 로고
    • The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: From idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy
    • B.J. Maron, M.S. Maron, and E.D. Wigle The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy J Am Coll Cardiol 54 2009 191 200
    • (2009) J Am Coll Cardiol , vol.54 , pp. 191-200
    • Maron, B.J.1    Maron, M.S.2    Wigle, E.D.3
  • 222
    • 0026546966 scopus 로고
    • Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy
    • J.A. Panza, R.K. Petrone, and L. Fananapazir Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 19 1992 91 99
    • (1992) J Am Coll Cardiol , vol.19 , pp. 91-99
    • Panza, J.A.1    Petrone, R.K.2    Fananapazir, L.3
  • 224
    • 0017233601 scopus 로고
    • Mid-ventricular obstruction: A variant of obstructive cardiomyopathy
    • R.E. Falicov, L. Resnekov, and S. Bharati Mid-ventricular obstruction: a variant of obstructive cardiomyopathy Am J Cardiol 37 1976 432 437
    • (1976) Am J Cardiol , vol.37 , pp. 432-437
    • Falicov, R.E.1    Resnekov, L.2    Bharati, S.3
  • 225
    • 0032497899 scopus 로고    scopus 로고
    • Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle
    • B.J. Maron, R.A. Nishimura, and G.K. Danielson Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle Circulation 98 1998 2505 2508 (Pubitemid 29001186)
    • (1998) Circulation , vol.98 , Issue.23 , pp. 2505-2508
    • Maron, B.J.1    Nishimura, R.A.2    Danielson, G.K.3
  • 226
    • 67749113510 scopus 로고    scopus 로고
    • Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy
    • J.B. Geske, P. Sorajja, and S.R. Ommen Left ventricular outflow tract gradient variability in hypertrophic cardiomyopathy Clin Cardiol 32 2009 397 402
    • (2009) Clin Cardiol , vol.32 , pp. 397-402
    • Geske, J.B.1    Sorajja, P.2    Ommen, S.R.3
  • 227
    • 0028902929 scopus 로고
    • Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy
    • H. Watkins, W.J. McKenna, and L. Thierfelder Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy N Engl J Med 332 1995 1058 1064
    • (1995) N Engl J Med , vol.332 , pp. 1058-1064
    • Watkins, H.1    McKenna, W.J.2    Thierfelder, L.3
  • 228
    • 0026573969 scopus 로고
    • Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy
    • H. Watkins, A. Rosenzweig, and D.S. Hwang Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy N Engl J Med 326 1992 1108 1114
    • (1992) N Engl J Med , vol.326 , pp. 1108-1114
    • Watkins, H.1    Rosenzweig, A.2    Hwang, D.S.3
  • 229
    • 0026485701 scopus 로고
    • Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations
    • H. Watkins, L. Thierfelder, and D.S. Hwang Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations J Clin Invest 90 1992 1666 1671
    • (1992) J Clin Invest , vol.90 , pp. 1666-1671
    • Watkins, H.1    Thierfelder, L.2    Hwang, D.S.3
  • 230
    • 77949881591 scopus 로고    scopus 로고
    • Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations
    • F. Girolami, C.Y. Ho, and C. Semsarian Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations J Am Coll Cardiol 55 2010 1444 1453
    • (2010) J Am Coll Cardiol , vol.55 , pp. 1444-1453
    • Girolami, F.1    Ho, C.Y.2    Semsarian, C.3
  • 231
    • 77952431044 scopus 로고    scopus 로고
    • The cardiac myosin binding protein C Arg502Trp mutation: A common cause of hypertrophic cardiomyopathy
    • A.J. Saltzman, D. Mancini-DiNardo, and C. Li The cardiac myosin binding protein C Arg502Trp mutation: a common cause of hypertrophic cardiomyopathy Circ Res 106 2010 1549 1552
    • (2010) Circ Res , vol.106 , pp. 1549-1552
    • Saltzman, A.J.1    Mancini-Dinardo, D.2    Li, C.3
  • 232
    • 75949086359 scopus 로고    scopus 로고
    • Multiple mutations in genetic cardiovascular disease: A marker of disease severity?
    • M. Kelly, and C. Semsarian Multiple mutations in genetic cardiovascular disease: a marker of disease severity? Circ Cardiovasc Genet 2 2009 182 190
    • (2009) Circ Cardiovasc Genet , vol.2 , pp. 182-190
    • Kelly, M.1    Semsarian, C.2
  • 234
    • 76349119911 scopus 로고    scopus 로고
    • Update on age at menarche in Italy: Toward the leveling off of the secular trend
    • F. Rigon, L. Bianchin, and S. Bernasconi Update on age at menarche in Italy: toward the leveling off of the secular trend J Adolesc Health 46 2010 238 244
    • (2010) J Adolesc Health , vol.46 , pp. 238-244
    • Rigon, F.1    Bianchin, L.2    Bernasconi, S.3
  • 235
    • 77955866434 scopus 로고    scopus 로고
    • Novel hypertrophic cardiomyopathy phenotype: Segmental hypertrophy isolated to the posterobasal left ventricular free wall
    • B.J. Maron, M.V. Sherrid, and T.S. Haas Novel hypertrophic cardiomyopathy phenotype: segmental hypertrophy isolated to the posterobasal left ventricular free wall Am J Cardiol 106 2010 750 752
    • (2010) Am J Cardiol , vol.106 , pp. 750-752
    • Maron, B.J.1    Sherrid, M.V.2    Haas, T.S.3
  • 237
    • 52649112149 scopus 로고    scopus 로고
    • Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
    • D.H. Kwon, R.M. Setser, and M. Thamilarasan Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy Heart 94 2008 1295 1301
    • (2008) Heart , vol.94 , pp. 1295-1301
    • Kwon, D.H.1    Setser, R.M.2    Thamilarasan, M.3
  • 239
    • 77951858842 scopus 로고    scopus 로고
    • Clinical application of cardiac CMR
    • M. Al-Mallah, and R.Y. Kwong Clinical application of cardiac CMR Rev Cardiovasc Med 10 2009 134 141
    • (2009) Rev Cardiovasc Med , vol.10 , pp. 134-141
    • Al-Mallah, M.1    Kwong, R.Y.2
  • 240
    • 77956339182 scopus 로고    scopus 로고
    • Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy
    • O. Bruder, A. Wagner, and C.J. Jensen Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 56 2010 875 887
    • (2010) J Am Coll Cardiol , vol.56 , pp. 875-887
    • Bruder, O.1    Wagner, A.2    Jensen, C.J.3
  • 241
    • 0242525744 scopus 로고    scopus 로고
    • Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease
    • DOI 10.1161/01.CIR.0000097110.55312.BF
    • P. Sorajja, S.R. Ommen, and R.A. Nishimura Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease Circulation 108 2003 2342 2348 (Pubitemid 37413540)
    • (2003) Circulation , vol.108 , Issue.19 , pp. 2342-2348
    • Sorajja, P.1    Ommen, S.R.2    Nishimura, R.A.3    Gersh, B.J.4    Berger, P.B.5    Tajik, A.J.6
  • 242
    • 33645052218 scopus 로고    scopus 로고
    • ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention
    • S.C. Smith Jr, T.E. Feldman, and J.W. Hirshfeld Jr ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention Circulation 113 2006 e166 e286
    • (2006) Circulation , vol.113
    • Smith, Jr.S.C.1    Feldman, T.E.2    Hirshfeld, Jr.J.W.3
  • 243
    • 0032558809 scopus 로고    scopus 로고
    • Myocardial bridging in children with hypertrophic cardiomyopathy - A risk factor for sudden death
    • DOI 10.1056/NEJM199810223391704
    • A.T. Yetman, B.W. McCrindle, and C. MacDonald Myocardial bridging in children with hypertrophic cardiomyopathy: a risk factor for sudden death N Engl J Med 339 1998 1201 1209 (Pubitemid 28482129)
    • (1998) New England Journal of Medicine , vol.339 , Issue.17 , pp. 1201-1209
    • Yetman, A.T.1    McCrindle, B.W.2    MacDonald, C.3    Freedom, R.M.4    Gow, R.5
  • 244
    • 0033667717 scopus 로고    scopus 로고
    • Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease
    • S.A. Mohiddin, D. Begley, and J. Shih Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease J Am Coll Cardiol 36 2000 2270 2278
    • (2000) J Am Coll Cardiol , vol.36 , pp. 2270-2278
    • Mohiddin, S.A.1    Begley, D.2    Shih, J.3
  • 247
    • 0027199824 scopus 로고
    • Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy
    • V. Dilsizian, R.O. Bonow, and S.E. Epstein Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy J Am Coll Cardiol 22 1993 796 804 (Pubitemid 23256942)
    • (1993) Journal of the American College of Cardiology , vol.22 , Issue.3 , pp. 796-804
    • Dilsizian, V.1    Bonow, R.O.2    Epstein, S.E.3    Fananapazir, L.4
  • 249
    • 0025829868 scopus 로고
    • Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography
    • P. Camici, G. Chiriatti, and R. Lorenzoni Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography J Am Coll Cardiol 17 1991 879 886
    • (1991) J Am Coll Cardiol , vol.17 , pp. 879-886
    • Camici, P.1    Chiriatti, G.2    Lorenzoni, R.3
  • 250
    • 0024560883 scopus 로고
    • Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy
    • R.O. Cannon III, C.L. McIntosh, and W.H. Schenke Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy Circulation 79 1989 766 775 (Pubitemid 19100535)
    • (1989) Circulation , vol.79 , Issue.4 , pp. 766-775
    • Cannon III, R.O.1    McIntosh, C.L.2    Schenke, W.H.3    Maron, B.J.4    Bonow, R.O.5    Epstein, S.E.6
  • 252
    • 33644600027 scopus 로고    scopus 로고
    • Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy
    • I. Olivotto, F. Cecchi, and R. Gistri Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy J Am Coll Cardiol 47 2006 1043 1048
    • (2006) J Am Coll Cardiol , vol.47 , pp. 1043-1048
    • Olivotto, I.1    Cecchi, F.2    Gistri, R.3
  • 254
    • 0033133612 scopus 로고    scopus 로고
    • Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities
    • B.J. Maron, R. Mathenge, and S.A. Casey Clinical profile of hypertrophic cardiomyopathy identified de novo in rural communities J Am Coll Cardiol 33 1999 1590 1595
    • (1999) J Am Coll Cardiol , vol.33 , pp. 1590-1595
    • Maron, B.J.1    Mathenge, R.2    Casey, S.A.3
  • 255
    • 0031984468 scopus 로고    scopus 로고
    • Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy
    • M.V. Sherrid, G. Pearle, and D.Z. Gunsburg Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy Circulation 97 1998 41 47 (Pubitemid 28036153)
    • (1998) Circulation , vol.97 , Issue.1 , pp. 41-47
    • Sherrid, M.V.1    Pearle, G.2    Gunsburg, D.Z.3
  • 256
    • 0019909159 scopus 로고
    • Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs
    • R.F. Alvares, and J.F. Goodwin Non-invasive assessment of diastolic function in hypertrophic cardiomyopathy on and off beta adrenergic blocking drugs Br Heart J 48 1982 204 212 (Pubitemid 12067700)
    • (1982) British Heart Journal , vol.48 , Issue.3 , pp. 204-212
    • Alvares, R.F.1    Goodwin, J.F.2
  • 257
    • 0022296412 scopus 로고
    • Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: An echographic study
    • DOI 10.1016/0002-8703(85)90357-6
    • C. Bourmayan, A. Razavi, and C. Fournier Effect of propranolol on left ventricular relaxation in hypertrophic cardiomyopathy: an echographic study Am Heart J 109 1985 1311 1316 (Pubitemid 16119649)
    • (1985) American Heart Journal , vol.109 , Issue.6 , pp. 1311-1316
    • Bourmayan, C.1    Razavi, A.2    Fournier, C.3
  • 259
    • 0020522972 scopus 로고
    • Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil
    • R.O. Bonow, T.M. Frederick, and S.L. Bacharach Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil Am J Cardiol 51 1983 1386 1391 (Pubitemid 13133084)
    • (1983) American Journal of Cardiology , vol.51 , Issue.8 , pp. 1386-1391
    • Bonow, R.O.1    Frederick, T.M.2    Bacharach, S.L.3
  • 260
    • 0021033453 scopus 로고
    • Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: Pressure-volume analysis with a nonimaging scintillation probe
    • R.O. Bonow, H.G. Ostrow, and D.R. Rosing Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe Circulation 68 1983 1062 1073 (Pubitemid 14238484)
    • (1983) Circulation , vol.68 , Issue.5 , pp. 1062-1073
    • Bonow, R.O.1    Ostrow, H.G.2    Rosing, D.R.3
  • 261
    • 0022381296 scopus 로고
    • Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: Short- and long-term effects
    • R.O. Bonow, V. Dilsizian, and D.R. Rosing Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects Circulation 72 1985 853 864 (Pubitemid 16245197)
    • (1985) Circulation , vol.72 , Issue.4 , pp. 853-864
    • Bonow, R.O.1    Dilsizian, V.2    Rosing, D.R.3
  • 262
    • 0023277870 scopus 로고
    • Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil
    • R.O. Bonow, D.F. Vitale, and B.J. Maron Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil J Am Coll Cardiol 9 1987 1108 1116 (Pubitemid 17065771)
    • (1987) Journal of the American College of Cardiology , vol.9 , Issue.5 , pp. 1108-1116
    • Bonow, R.O.1    Vitale, D.F.2    Maron, B.J.3
  • 266
    • 0020326424 scopus 로고
    • Muscular subaortic stenosis. Hemodynamic and clinical improvement after disopyramide
    • C. Pollick Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide N Engl J Med 307 1982 997 999 (Pubitemid 12018959)
    • (1982) New England Journal of Medicine , vol.307 , Issue.16 , pp. 997-999
    • Pollick, C.1
  • 267
    • 0029043605 scopus 로고
    • Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
    • U. Sigwart Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy Lancet 346 1995 211 214
    • (1995) Lancet , vol.346 , pp. 211-214
    • Sigwart, U.1
  • 268
    • 53849090989 scopus 로고    scopus 로고
    • Resection-plication-release for hypertrophic cardiomyopathy: Clinical and echocardiographic follow-up
    • S.K. Balaram, L. Tyrie, and M.V. Sherrid Resection-plication-release for hypertrophic cardiomyopathy: clinical and echocardiographic follow-up Ann Thorac Surg 86 2008 1539 1544
    • (2008) Ann Thorac Surg , vol.86 , pp. 1539-1544
    • Balaram, S.K.1    Tyrie, L.2    Sherrid, M.V.3
  • 269
    • 58149098484 scopus 로고    scopus 로고
    • Abnormally thickened papillary muscle resulting in dynamic left ventricular outflow tract obstruction: An unusual presentation of hypertrophic cardiomyopathy
    • B.A. Austin, D.H. Kwon, and N.G. Smedira Abnormally thickened papillary muscle resulting in dynamic left ventricular outflow tract obstruction: an unusual presentation of hypertrophic cardiomyopathy J Am Soc Echocardiogr 22 2009 105 106
    • (2009) J Am Soc Echocardiogr , vol.22 , pp. 105-106
    • Austin, B.A.1    Kwon, D.H.2    Smedira, N.G.3
  • 270
    • 0027182298 scopus 로고
    • Echocardiographic assessment of mitral valve size in obstructive hypertrophic cardiomyopathy: Anatomic validation from mitral valve specimen
    • H.G. Klues, M.A. Proschan, and A.L. Dollar Echocardiographic assessment of mitral valve size in obstructive hypertrophic cardiomyopathy: anatomic validation from mitral valve specimen Circulation 88 1993 548 555 (Pubitemid 23228054)
    • (1993) Circulation , vol.88 , Issue.2 , pp. 548-555
    • Klues, H.G.1    Proschan, M.A.2    Dollar, A.L.3    Spirito, P.4    Roberts, W.C.5    Maron, B.J.6
  • 272
    • 0028726273 scopus 로고
    • Surgical correction of hypertrophic obstructive cardiomyopathy with combined myectomy, mobilisation and partial excision of the papillary muscles
    • F.A. Schoendube, H.G. Klues, and S. Reith Surgical correction of hypertrophic obstructive cardiomyopathy with combined myectomy, mobilisation and partial excision of the papillary muscles Eur J Cardiothorac Surg 8 1994 603 608
    • (1994) Eur J Cardiothorac Surg , vol.8 , pp. 603-608
    • Schoendube, F.A.1    Klues, H.G.2    Reith, S.3
  • 273
    • 0026532927 scopus 로고
    • Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy
    • H.G. Klues, B.J. Maron, and A.L. Dollar Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy Circulation 85 1992 1651 1660
    • (1992) Circulation , vol.85 , pp. 1651-1660
    • Klues, H.G.1    Maron, B.J.2    Dollar, A.L.3
  • 274
    • 0029832010 scopus 로고    scopus 로고
    • Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy
    • R.B. McCully, R.A. Nishimura, and A.J. Tajik Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy Circulation 94 1996 467 471 (Pubitemid 26266133)
    • (1996) Circulation , vol.94 , Issue.3 , pp. 467-471
    • McCully, R.B.1    Nishimura, R.A.2    Tajik, A.J.3    Schaff, H.V.4    Danielson, G.K.5
  • 275
    • 0030890448 scopus 로고    scopus 로고
    • Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest
    • F. Gadler, C. Linde, and A. Juhlin-Dannfelt Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest Eur Heart J 18 1997 636 642 (Pubitemid 27182358)
    • (1997) European Heart Journal , vol.18 , Issue.4 , pp. 636-642
    • Gadler, F.1    Linde, C.2    Juhlin-Dannfelt, A.3    Ribeiro, A.4    Ryden, L.5
  • 277
    • 40149087315 scopus 로고    scopus 로고
    • Myths about surgical myectomy: Rumors of its death have been greatly exaggerated
    • B.J. Maron, S.R. Ommen, and R.A. Nishimura Myths about surgical myectomy: rumors of its death have been greatly exaggerated Am J Cardiol 101 2008 887 889
    • (2008) Am J Cardiol , vol.101 , pp. 887-889
    • Maron, B.J.1    Ommen, S.R.2    Nishimura, R.A.3
  • 278
    • 23744499778 scopus 로고    scopus 로고
    • Catheter-based septalablation for symptomatic hypertrophic obstructive cardiomyopathy: Follow-up results of the TASH-registry of the German Cardiac Society
    • DOI 10.1007/s00392-005-0256-8
    • L. Faber, H. Seggewiss, and F.H. Gietzen Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society Z Kardiol 94 2005 516 523 (Pubitemid 41124491)
    • (2005) Zeitschrift fur Kardiologie , vol.94 , Issue.8 , pp. 516-523
    • Faber, L.1    Seggewiss, H.2    Gietzen, F.H.3    Kuhn, H.4    Boekstegers, P.5    Neuhaus, L.6    Seipel, L.7    Horstkotte, D.8
  • 279
    • 14944368967 scopus 로고    scopus 로고
    • A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy - The Baylor experience (1996-2002)
    • V.L. Fernandes, S.F. Nagueh, and W. Wang A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: the Baylor experience (19962002) Clin Cardiol 28 2005 124 130 (Pubitemid 40364503)
    • (2005) Clinical Cardiology , vol.28 , Issue.3 , pp. 124-130
    • Fernandes, V.L.1    Nagueh, S.F.2    Franklin, J.3    Wang, W.4    Roberts, R.5    Spencer III, W.H.6
  • 280
    • 0033864655 scopus 로고    scopus 로고
    • Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: One-year follow-up
    • N.M. Lakkis, S.F. Nagueh, and J.K. Dunn Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up J Am Coll Cardiol 36 2000 852 855
    • (2000) J Am Coll Cardiol , vol.36 , pp. 852-855
    • Lakkis, N.M.1    Nagueh, S.F.2    Dunn, J.K.3
  • 281
    • 0038826287 scopus 로고    scopus 로고
    • Complete heart block: Determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy
    • DOI 10.1016/S0735-1097(03)00623-5
    • S.M. Chang, S.F. Nagueh, and W.H. Spencer III Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy J Am Coll Cardiol 42 2003 296 300 (Pubitemid 36851421)
    • (2003) Journal of the American College of Cardiology , vol.42 , Issue.2 , pp. 296-300
    • Chang, S.M.1    Nagueh, S.F.2    Spencer III, W.H.3    Lakkis, N.M.4
  • 284
    • 0026744186 scopus 로고
    • Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy
    • L.H. Cohn, H. Trehan, and J.J. Collins Jr Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy Am J Cardiol 70 1992 657 660
    • (1992) Am J Cardiol , vol.70 , pp. 657-660
    • Cohn, L.H.1    Trehan, H.2    Collins, Jr.J.J.3
  • 285
    • 0000513035 scopus 로고
    • Surgical relief of diffuse subvalvular aortic stenosis
    • J.W. Kirklin, and F.H. Ellis Jr Surgical relief of diffuse subvalvular aortic stenosis Circulation 24 1961 739 742
    • (1961) Circulation , vol.24 , pp. 739-742
    • Kirklin, J.W.1    Ellis, Jr.F.H.2
  • 286
    • 0023761191 scopus 로고
    • Current operative treatment of obstructive hypertrophic cardiomyopathy
    • C.L. McIntosh, and B.J. Maron Current operative treatment of obstructive hypertrophic cardiomyopathy Circulation 78 1988 487 495
    • (1988) Circulation , vol.78 , pp. 487-495
    • McIntosh, C.L.1    Maron, B.J.2
  • 287
    • 0024462678 scopus 로고
    • Results of operation for hypertrophic obstructive cardiomyopathy in children and adults less than 40 years of age
    • R. Mohr, H.V. Schaff, and F.J. Puga Results of operation for hypertrophic obstructive cardiomyopathy in children and adults less than 40 years of age Circulation 80 1989 I191 I196
    • (1989) Circulation , vol.80
    • Mohr, R.1    Schaff, H.V.2    Puga, F.J.3
  • 288
    • 0001651556 scopus 로고
    • Surgical treatment of idiopathic hypertrophic subaortic stenosis: Technic and hemodynamic results of subaortic ventriculomyotomy
    • A.G. Morrow, and E.C. Brockenbrough Surgical treatment of idiopathic hypertrophic subaortic stenosis: technic and hemodynamic results of subaortic ventriculomyotomy Ann Surg 154 1961 181 189
    • (1961) Ann Surg , vol.154 , pp. 181-189
    • Morrow, A.G.1    Brockenbrough, E.C.2
  • 289
    • 0029870435 scopus 로고    scopus 로고
    • Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy
    • DOI 10.1016/S0022-5223(96)70310-0
    • R.C. Robbins, and E.B. Stinson Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy J Thorac Cardiovasc Surg 111 1996 586 594 (Pubitemid 26087722)
    • (1996) Journal of Thoracic and Cardiovascular Surgery , vol.111 , Issue.3 , pp. 586-594
    • Robbins, R.C.1    Stinson, E.B.2    Daily, P.O.3
  • 291
    • 0023637204 scopus 로고
    • Results of surgery for hypertrophic obstructive cardiomyopathy
    • W.G. Williams, E.D. Wigle, and H. Rakowski Results of surgery for hypertrophic obstructive cardiomyopathy Circulation 76 1987 V104 V108
    • (1987) Circulation , vol.76
    • Williams, W.G.1    Wigle, E.D.2    Rakowski, H.3
  • 292
    • 0013540741 scopus 로고
    • Surgical intervention and support for cardiomyopathies of childhood
    • W.G. Williams, and I.M. Rebeyka Surgical intervention and support for cardiomyopathies of childhood Prog Pediatr Cardiol 1 1992 61 71
    • (1992) Prog Pediatr Cardiol , vol.1 , pp. 61-71
    • Williams, W.G.1    Rebeyka, I.M.2
  • 293
    • 0028827619 scopus 로고
    • Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus
    • F.A. Schoendube, H.G. Klues, and S. Reith Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus Circulation 92 suppl 9 1995 II122 II127
    • (1995) Circulation , vol.92 , Issue.SUPPL. 9
    • Schoendube, F.A.1    Klues, H.G.2    Reith, S.3
  • 294
    • 34447328477 scopus 로고    scopus 로고
    • Surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy
    • DOI 10.1161/CIRCULATIONAHA.107.691378, PII 0000301720070710000013
    • B.J. Maron Controversies in cardiovascular medicine: surgical myectomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy Circulation 116 2007 196 206 (Pubitemid 47057526)
    • (2007) Circulation , vol.116 , Issue.2 , pp. 196-206
    • Maron, B.J.1
  • 295
    • 0037317016 scopus 로고    scopus 로고
    • Obstructive hypertrophic cardiomyopathy: Echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction
    • DOI 10.1016/S0003-4975(02)04546-0, PII S0003497502045460
    • M.V. Sherrid, F.A. Chaudhry, and D.G. Swistel Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction Ann Thorac Surg 75 2003 620 632 (Pubitemid 36184532)
    • (2003) Annals of Thoracic Surgery , vol.75 , Issue.2 , pp. 620-632
    • Sherrid, M.V.1    Chaudhry, F.A.2    Swistel, D.G.3
  • 296
    • 0020516240 scopus 로고
    • Systolic anterior motion of the posterior mitral leaflet: A previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy
    • B.J. Maron, A.M. Harding, and P. Spirito Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy Circulation 68 1983 282 293 (Pubitemid 13028904)
    • (1983) Circulation , vol.68 , Issue.2 , pp. 282-293
    • Maron, B.J.1    Harding, A.M.2    Spirito, P.3
  • 297
    • 0021702076 scopus 로고
    • Morphologic determinants of hemodynamic state after ventricular septal myotomy-myectomy in patients with obstructive hypertrophic cardiomyopathy: M mode and two-dimensional echocardiographic assessment
    • P. Spirito, B.J. Maron, and D.R. Rosing Morphologic determinants of hemodynamic state after ventricular septal myotomy-myectomy in patients with obstructive hypertrophic cardiomyopathy: M mode and two-dimensional echocardiographic assessment Circulation 70 1984 984 995 (Pubitemid 15219358)
    • (1984) Circulation , vol.70 , Issue.6 , pp. 984-995
    • Spirito, P.1    Maron, B.J.2    Rosing, D.R.3
  • 298
    • 1642363460 scopus 로고    scopus 로고
    • Hypertrophic obstructive cardiomyopathy
    • DOI 10.1056/NEJMcp030779
    • R.A. Nishimura, and D.R. Holmes Jr Clinical practice: hypertrophic obstructive cardiomyopathy N Engl J Med 350 2004 1320 1327 (Pubitemid 38375367)
    • (2004) New England Journal of Medicine , vol.350 , Issue.13 , pp. 1320-1327
    • Nishimura, R.A.1    Holmes Jr., D.R.2
  • 300
    • 77954752046 scopus 로고    scopus 로고
    • Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: A word of caution
    • F.J. Ten Cate, O.I. Soliman, and M. Michels Long-term outcome of alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: a word of caution Circ Heart Fail 3 2010 362 369
    • (2010) Circ Heart Fail , vol.3 , pp. 362-369
    • Ten Cate, F.J.1    Soliman, O.I.2    Michels, M.3
  • 303
    • 0025997375 scopus 로고
    • Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy: Significance in producing left ventricular outflow obstruction
    • H.G. Klues, W.C. Roberts, and B.J. Maron Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy: significance in producing left ventricular outflow obstruction Circulation 84 1991 1188 1197
    • (1991) Circulation , vol.84 , pp. 1188-1197
    • Klues, H.G.1    Roberts, W.C.2    Maron, B.J.3
  • 304
    • 0032401669 scopus 로고    scopus 로고
    • Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Results with respect to intraprocedural myocardial contrast echocardiography
    • L. Faber, H. Seggewiss, and U. Gleichmann Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: results with respect to intraprocedural myocardial contrast echocardiography Circulation 98 1998 2415 2421 (Pubitemid 28549785)
    • (1998) Circulation , vol.98 , Issue.22 , pp. 2415-2421
    • Faber, L.1    Seggewiss, H.2    Gleichmann, U.3
  • 306
    • 0032768509 scopus 로고    scopus 로고
    • Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: Detection of threatening myocardial necrosis distant from the septal target area
    • DOI 10.1002/(SICI)1522-726X(199908)47:4<462::AID-CCD16>3.0.CO;2-9
    • L. Faber, H. Seggewiss, and P. Ziemssen Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area Catheter Cardiovasc Interv 47 1999 462 466 (Pubitemid 29360372)
    • (1999) Catheterization and Cardiovascular Interventions , vol.47 , Issue.4 , pp. 462-466
    • Faber, L.1    Seggewiss, H.2    Ziemssen, P.3    Gleichmann, U.4
  • 308
    • 59049084482 scopus 로고    scopus 로고
    • Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: Ultra-low dose of alcohol (1 ml) is still effective
    • J. Veselka, D. Zemanek, and P. Tomasov Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: ultra-low dose of alcohol (1 ml) is still effective Heart Vessels 24 2009 27 31
    • (2009) Heart Vessels , vol.24 , pp. 27-31
    • Veselka, J.1    Zemanek, D.2    Tomasov, P.3
  • 311
    • 0035165382 scopus 로고    scopus 로고
    • Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy
    • DOI 10.1016/S0735-1097(00)01045-7, PII S0735109700010457
    • R. Flores-Ramirez, N.M. Lakkis, and K.J. Middleton Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy J Am Coll Cardiol 37 2001 208 214 (Pubitemid 32051740)
    • (2001) Journal of the American College of Cardiology , vol.37 , Issue.1 , pp. 208-214
    • Flores-Ramirez, R.1    Lakkis, N.M.2    Middleton, K.J.3    Killip, D.4    Spencer III, W.H.5    Nagueh, S.F.6
  • 312
    • 0032793393 scopus 로고    scopus 로고
    • Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion
    • H. Kuhn, F.H. Gietzen, and M. Schafers Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion Eur Heart J 20 1999 1808 1817
    • (1999) Eur Heart J , vol.20 , pp. 1808-1817
    • Kuhn, H.1    Gietzen, F.H.2    Schafers, M.3
  • 313
    • 0037162385 scopus 로고    scopus 로고
    • Acute effect of nonsurgical septal reduction therapy on regional left ventricular asynchrony in patients with hypertrophic obstructive cardiomyopathy
    • DOI 10.1161/01.CIR.0000025418.96995.ED
    • T.H. Park, N.M. Lakkis, and K.J. Middleton Acute effect of nonsurgical septal reduction therapy on regional left ventricular asynchrony in patients with hypertrophic obstructive cardiomyopathy Circulation 106 2002 412 415 (Pubitemid 34803683)
    • (2002) Circulation , vol.106 , Issue.4 , pp. 412-415
    • Park, T.-H.1    Lakkis, N.M.2    Middleton, K.J.3    Franklin, J.4    Zoghbi, W.A.5    Quinones, M.A.6    Spencer III, W.H.7    Nagueh, S.F.8
  • 314
    • 0034117493 scopus 로고    scopus 로고
    • New treatment methods for patients with hypertrophic obstructive cardiomyopathy
    • DOI 10.1097/00001573-200005000-00009
    • N. Lakkis New treatment methods for patients with hypertrophic obstructive cardiomyopathy Curr Opin Cardiol 15 2000 172 177 (Pubitemid 30326639)
    • (2000) Current Opinion in Cardiology , vol.15 , Issue.3 , pp. 172-177
    • Lakkis, N.1
  • 315
    • 0035916930 scopus 로고    scopus 로고
    • Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy
    • W. Mazur, S.F. Nagueh, and N.M. Lakkis Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy Circulation 103 2001 1492 1496 (Pubitemid 32226254)
    • (2001) Circulation , vol.103 , Issue.11 , pp. 1492-1496
    • Mazur, W.1    Nagueh, S.F.2    Lakkis, N.M.3    Middleton, K.J.4    Killip, D.5    Roberts, R.6    Spencer III, W.H.7
  • 317
    • 0034021370 scopus 로고    scopus 로고
    • Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: Long term follow up of the first series of 25 patients
    • L. Faber, A. Meissner, and P. Ziemssen Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients Heart 83 2000 326 331 (Pubitemid 30313339)
    • (2000) Heart , vol.83 , Issue.3 , pp. 326-331
    • Faber, L.1    Meissner, A.2    Ziemssen, P.3    Seggewiss, H.4
  • 318
    • 0032823413 scopus 로고    scopus 로고
    • Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy
    • DOI 10.1053/euhj.1999.1520
    • F.H. Gietzen, C.J. Leuner, and U. Raute-Kreinsen Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH): catheter interventional treatment for hypertrophic obstructive cardiomyopathy Eur Heart J 20 1999 1342 1354 (Pubitemid 29429721)
    • (1999) European Heart Journal , vol.20 , Issue.18 , pp. 1342-1354
    • Gietzen, F.H.1    Leuner, Ch.J.2    Raute-Kreinsen, U.3    Dellmann, A.4    Hegselmann, J.5    Strunk-Mueller, C.6    Kuhn, H.J.7
  • 319
    • 0345003773 scopus 로고    scopus 로고
    • Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy
    • DOI 10.1016/S0002-9149(99)00063-6, PII S0002914999000636
    • J.J. Kim, C.W. Lee, and S.W. Park Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy Am J Cardiol 83 1999 1220 1223 (Pubitemid 29183921)
    • (1999) American Journal of Cardiology , vol.83 , Issue.8 , pp. 1220-1223
    • Kim, J.-J.1    Lee, C.W.2    Park, S.-W.3    Hong, M.-K.4    Lim, H.-Y.5    Song, J.-K.6    Jin, Y.-S.7    Park, S.-J.8
  • 320
    • 35748958453 scopus 로고    scopus 로고
    • Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation
    • DOI 10.1016/j.amjcard.2007.06.063, PII S0002914907015457
    • E.R. Serber, S.F. Sears, and C.D. Nielsen Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation Am J Cardiol 100 2007 1592 1597 (Pubitemid 350050865)
    • (2007) American Journal of Cardiology , vol.100 , Issue.10 , pp. 1592-1597
    • Serber, E.R.1    Sears, S.F.2    Nielsen, C.D.3    Spencer III, W.H.4    Smith, K.M.5
  • 321
    • 77953655040 scopus 로고    scopus 로고
    • Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: Comparative rates of overall mortality and sudden cardiac death after treatment
    • R.A. Leonardi, E.P. Kransdorf, and D.L. Simel Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy: comparative rates of overall mortality and sudden cardiac death after treatment Circ Cardiovasc Interv 3 2010 97 104
    • (2010) Circ Cardiovasc Interv , vol.3 , pp. 97-104
    • Leonardi, R.A.1    Kransdorf, E.P.2    Simel, D.L.3
  • 322
    • 65949112259 scopus 로고    scopus 로고
    • Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: A meta-analysis
    • M. Alam, H. Dokainish, and N.M. Lakkis Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis Eur Heart J 30 2009 1080 1087
    • (2009) Eur Heart J , vol.30 , pp. 1080-1087
    • Alam, M.1    Dokainish, H.2    Lakkis, N.M.3
  • 323
    • 34547937694 scopus 로고    scopus 로고
    • Surgical Myectomy Versus Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy. Will There Ever Be a Randomized Trial?
    • DOI 10.1016/j.jacc.2007.05.018, PII S0735109707017895
    • I. Olivotto, S.R. Ommen, and M.S. Maron Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: will there ever be a randomized trial? J Am Coll Cardiol 50 2007 831 834 (Pubitemid 47268741)
    • (2007) Journal of the American College of Cardiology , vol.50 , Issue.9 , pp. 831-834
    • Olivotto, I.1    Ommen, S.R.2    Maron, M.S.3    Cecchi, F.4    Maron, B.J.5
  • 324
    • 77953681907 scopus 로고    scopus 로고
    • Septal reduction therapy for obstructive hypertrophic cardiomyopathy and sudden death: What statistics cannot tell you
    • R.A. Nishimura, and S.R. Ommen Septal reduction therapy for obstructive hypertrophic cardiomyopathy and sudden death: what statistics cannot tell you Circ Cardiovasc Interv 3 2010 91 93
    • (2010) Circ Cardiovasc Interv , vol.3 , pp. 91-93
    • Nishimura, R.A.1    Ommen, S.R.2
  • 326
    • 34249278053 scopus 로고    scopus 로고
    • Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: Managing the risk of procedure-related AV conduction disturbances
    • DOI 10.1016/j.ijcard.2006.07.179, PII S0167527306009624
    • L. Faber, D. Welge, and D. Fassbender Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances Int J Cardiol 119 2007 163 167 (Pubitemid 46818511)
    • (2007) International Journal of Cardiology , vol.119 , Issue.2 , pp. 163-167
    • Faber, L.1    Welge, D.2    Fassbender, D.3    Schmidt, H.K.4    Horstkotte, D.5    Seggewiss, H.6
  • 327
    • 1842789044 scopus 로고    scopus 로고
    • Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy
    • DOI 10.1016/j.amjcard.2003.12.065, PII S0002914904000402
    • W. Reinhard, F.J. Ten Cate, and M. Scholten Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy Am J Cardiol 93 2004 1064 1066 (Pubitemid 38479472)
    • (2004) American Journal of Cardiology , vol.93 , Issue.8 , pp. 1064-1066
    • Reinhard, W.1    Ten Cate, F.J.2    Scholten, M.3    De Laat, L.E.4    Vos, J.5
  • 329
    • 6944253543 scopus 로고    scopus 로고
    • Ventricular tachycardia complicating alcohol septal ablation [7]
    • DOI 10.1056/NEJM200410283511824
    • C.M. Boltwood Jr, W. Chien, and T. Ports Ventricular tachycardia complicating alcohol septal ablation N Engl J Med 351 2004 1914 1915 (Pubitemid 39426334)
    • (2004) New England Journal of Medicine , vol.351 , Issue.18 , pp. 1914-1915
    • Boltwood Jr., C.M.1    Chien, W.2    Ports, T.3
  • 331
    • 0031713571 scopus 로고    scopus 로고
    • Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy
    • J. Kazmierczak, Z. Kornacewicz-Jach, and M. Kisly Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy Heart 80 1998 257 262 (Pubitemid 28440344)
    • (1998) Heart , vol.80 , Issue.3 , pp. 257-262
    • Kazmierczak, J.1    Kornacewicz-Jach, Z.2    Kisly, M.3    Gil, R.4    Wojtarowicz, A.5
  • 333
    • 4644237499 scopus 로고    scopus 로고
    • Monomorphic ventricular tachycardia: A late complication of percutaneous alcohol septal ablation for hypertrophic cardiomyopathy
    • DOI 10.1097/00000441-200409000-00011
    • J.B. McGregor, A. Rahman, and S. Rosanio Monomorphic ventricular tachycardia: a late complication of percutaneous alcohol septal ablation for hypertrophic cardiomyopathy Am J Med Sci 328 2004 185 188 (Pubitemid 39295868)
    • (2004) American Journal of the Medical Sciences , vol.328 , Issue.3 , pp. 185-188
    • McGregor, J.B.1    Rahman, A.2    Rosanio, S.3    Ware, D.4    Birnbaum, Y.5    Saeed, M.6
  • 334
    • 67649359494 scopus 로고    scopus 로고
    • Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy
    • P.A. Noseworthy, M.A. Rosenberg, and M.A. Fifer Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy Am J Cardiol 104 2009 128 132
    • (2009) Am J Cardiol , vol.104 , pp. 128-132
    • Noseworthy, P.A.1    Rosenberg, M.A.2    Fifer, M.A.3
  • 335
    • 33645092694 scopus 로고    scopus 로고
    • Sustained ventricular tachycardia following alcohol septal ablation for hypertrophic obstructive cardiomyopathy
    • DOI 10.1111/j.1540-8159.2005.00278.x
    • R.D. Simon, F.A. Crawford III, and W.H. Spencer III Sustained ventricular tachycardia following alcohol septal ablation for hypertrophic obstructive cardiomyopathy Pacing Clin Electrophysiol 28 2005 1354 1356 (Pubitemid 43951397)
    • (2005) PACE - Pacing and Clinical Electrophysiology , vol.28 , Issue.12 , pp. 1354-1356
    • Simon, R.D.B.1    Crawford III, F.A.2    Spencer III, W.H.3    Gold, M.R.4
  • 336
    • 55549112589 scopus 로고    scopus 로고
    • Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy
    • F.A. Cuoco, W.H. Spencer III, and V.L. Fernandes Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy J Am Coll Cardiol 52 2008 1718 1723
    • (2008) J Am Coll Cardiol , vol.52 , pp. 1718-1723
    • Cuoco, F.A.1    Spencer Iii, W.H.2    Fernandes, V.L.3
  • 337
    • 76449100758 scopus 로고    scopus 로고
    • Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy
    • S. Agarwal, E.M. Tuzcu, and M.Y. Desai Updated meta-analysis of septal alcohol ablation versus myectomy for hypertrophic cardiomyopathy J Am Coll Cardiol 55 2010 823 834
    • (2010) J Am Coll Cardiol , vol.55 , pp. 823-834
    • Agarwal, S.1    Tuzcu, E.M.2    Desai, M.Y.3
  • 338
    • 84891747812 scopus 로고    scopus 로고
    • Deleted in proof
    • Deleted in proof.
  • 339
    • 0028650316 scopus 로고
    • Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy
    • L. Fananapazir, N.D. Epstein, and R.V. Curiel Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy Circulation 90 1994 2731 2742
    • (1994) Circulation , vol.90 , pp. 2731-2742
    • Fananapazir, L.1    Epstein, N.D.2    Curiel, R.V.3
  • 340
    • 0026539281 scopus 로고
    • Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy
    • X. Jeanrenaud, J.J. Goy, and L. Kappenberger Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy Lancet 339 1992 1318 1323
    • (1992) Lancet , vol.339 , pp. 1318-1323
    • Jeanrenaud, X.1    Goy, J.J.2    Kappenberger, L.3
  • 341
    • 0023806940 scopus 로고
    • Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy
    • K. McDonald, E. McWilliams, and B. O'Keeffe Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy Eur Heart J 9 1988 893 898
    • (1988) Eur Heart J , vol.9 , pp. 893-898
    • McDonald, K.1    McWilliams, E.2    O'Keeffe, B.3
  • 342
    • 0033002903 scopus 로고    scopus 로고
    • Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy
    • DOI 10.1016/S0002-9149(98)01065-0, PII S0002914998010650
    • C. Linde, F. Gadler, and L. Kappenberger Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy: PIC Study Group Pacing In Cardiomyopathy Am J Cardiol 83 1999 903 907 (Pubitemid 29143129)
    • (1999) American Journal of Cardiology , vol.83 , Issue.6 , pp. 903-907
    • Linde, C.1    Gadler, F.2    Kappenberger, L.3    Ryden, L.4
  • 343
  • 344
    • 67649132593 scopus 로고    scopus 로고
    • Long-term survival after cardiac arrest in hypertrophic cardiomyopathy
    • B.J. Maron, T.S. Haas, and K.M. Shannon Long-term survival after cardiac arrest in hypertrophic cardiomyopathy Heart Rhythm 6 2009 993 997
    • (2009) Heart Rhythm , vol.6 , pp. 993-997
    • Maron, B.J.1    Haas, T.S.2    Shannon, K.M.3
  • 345
    • 70449514988 scopus 로고    scopus 로고
    • Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy
    • J.R. Gimeno, M. Tome-Esteban, and C. Lofiego Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy Eur Heart J 30 2009 2599 2605
    • (2009) Eur Heart J , vol.30 , pp. 2599-2605
    • Gimeno, J.R.1    Tome-Esteban, M.2    Lofiego, C.3
  • 347
    • 0031978633 scopus 로고    scopus 로고
    • Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: Assessment in an unselected non-referral based patient population
    • F. Cecchi, I. Olivotto, and A. Montereggi Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population Heart 79 1998 331 336 (Pubitemid 28197746)
    • (1998) Heart , vol.79 , Issue.4 , pp. 331-336
    • Cecchi, F.1    Olivotto, I.2    Montereggi, A.3    Squillatini, G.4    Dolara, A.5    Maron, B.J.6
  • 348
    • 0032502022 scopus 로고    scopus 로고
    • Spontaneous variability of left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy
    • A.M. Kizilbash, S.K. Heinle, and P.A. Grayburn Spontaneous variability of left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy Circulation 97 1998 461 466 (Pubitemid 28090218)
    • (1998) Circulation , vol.97 , Issue.5 , pp. 461-466
    • Kizilbash, A.M.1    Heinle, S.K.2    Grayburn, P.A.3
  • 350
    • 0031933491 scopus 로고    scopus 로고
    • Molecular genetic basis of hypertrophic cardiomyopathy: Genetic markers for sudden cardiac death
    • A.J. Marian, and R. Roberts Molecular genetic basis of hypertrophic cardiomyopathy: genetic markers for sudden cardiac death J Cardiovasc Electrophysiol 9 1998 88 99 (Pubitemid 28086489)
    • (1998) Journal of Cardiovascular Electrophysiology , vol.9 , Issue.1 , pp. 88-99
    • Marian, A.J.1    Roberts, R.2
  • 351
    • 0030882952 scopus 로고    scopus 로고
    • Sudden cardiac death in familial hypertrophic cardiomyopathy: Are "benign" mutations really benign?
    • C. Semsarian, B. Yu, and C. Ryce Sudden cardiac death in familial hypertrophic cardiomyopathy: are "benign" mutations really benign? Pathology 29 1997 305 308
    • (1997) Pathology , vol.29 , pp. 305-308
    • Semsarian, C.1    Yu, B.2    Ryce, C.3
  • 352
    • 0037134832 scopus 로고    scopus 로고
    • Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: A comprehensive outpatient perspective
    • DOI 10.1016/S0735-1097(02)01900-9, PII S0735109702019009
    • M.J. Ackerman, S.L. VanDriest, and S.R. Ommen Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective J Am Coll Cardiol 39 2002 2042 2048 (Pubitemid 34628288)
    • (2002) Journal of the American College of Cardiology , vol.39 , Issue.12 , pp. 2042-2048
    • Ackerman, M.J.1    VanDriest, S.L.2    Ommen, S.R.3    Will, M.L.4    Nishimura, R.A.5    Tajik A.Jamil6    Gersh, B.J.7
  • 353
    • 0346059369 scopus 로고    scopus 로고
    • From malignant mutations to malignant domains: The continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathy
    • S.L. Van Driest, B.J. Maron, and M.J. Ackerman From malignant mutations to malignant domains: the continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathy Heart 90 2004 7 8 (Pubitemid 38064529)
    • (2004) Heart , vol.90 , Issue.1 , pp. 7-8
    • Van Driest, S.L.1    Maron, B.J.2    Ackerman, M.J.3
  • 354
    • 0036153781 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy: Management, risk stratification, and prevention of sudden death
    • W.J. McKenna, and E.R. Behr Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death Heart 87 2002 169 176 (Pubitemid 34098386)
    • (2002) Heart , vol.87 , Issue.2 , pp. 169-176
    • McKenna, W.J.1    Behr, E.R.2
  • 355
    • 65549134228 scopus 로고    scopus 로고
    • Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy
    • G. Lin, R.A. Nishimura, and B.J. Gersh Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy Heart 95 2009 709 714
    • (2009) Heart , vol.95 , pp. 709-714
    • Lin, G.1    Nishimura, R.A.2    Gersh, B.J.3
  • 356
    • 25444444353 scopus 로고    scopus 로고
    • Lessons from the failure and recall of an implantable cardioverter- defibrillator
    • DOI 10.1161/CIRCULATIONAHA.105.580381
    • R.G. Hauser, and B.J. Maron Lessons from the failure and recall of an implantable cardioverter-defibrillator Circulation 112 2005 2040 2042 (Pubitemid 41377424)
    • (2005) Circulation , vol.112 , Issue.13 , pp. 2040-2042
    • Hauser, R.G.1    Maron, B.J.2
  • 357
    • 79751531987 scopus 로고    scopus 로고
    • Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: Implications for patient management
    • R.G. Hauser, W.H. Maisel, and P.A. Friedman Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management Circulation 123 2011 358 363
    • (2011) Circulation , vol.123 , pp. 358-363
    • Hauser, R.G.1    Maisel, W.H.2    Friedman, P.A.3
  • 358
    • 22844445678 scopus 로고    scopus 로고
    • Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy
    • DOI 10.1016/j.hrthm.2005.05.008, PII S1547527105016528
    • A.K. Almquist, J.V. Montgomery, and T.S. Haas Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy Heart Rhythm 2 2005 814 819 (Pubitemid 41038399)
    • (2005) Heart Rhythm , vol.2 , Issue.8 , pp. 814-819
    • Almquist, A.K.1    Montgomery, J.V.2    Haas, T.S.3    Maron, B.J.4
  • 360
    • 56849109348 scopus 로고    scopus 로고
    • Bethesda conference #36 and the european society of cardiology consensus recommendations revisited: A comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities
    • A. Pelliccia, D.P. Zipes, and B.J. Maron Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited: a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities J Am Coll Cardiol 52 2008 1990 1996
    • (2008) J Am Coll Cardiol , vol.52 , pp. 1990-1996
    • Pelliccia, A.1    Zipes, D.P.2    Maron, B.J.3
  • 361
    • 0035231635 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy in the elderly: Significance of atrial fibrillation
    • Y. Doi, and H. Kitaoka Hypertrophic cardiomyopathy in the elderly: significance of atrial fibrillation J Cardiol 37 suppl 1 2001 133 138
    • (2001) J Cardiol , vol.37 , Issue.SUPPL. 1 , pp. 133-138
    • Doi, Y.1    Kitaoka, H.2
  • 362
    • 0020685464 scopus 로고
    • Side effects of long-term amiodarone therapy
    • L. Harris, W.J. McKenna, and E. Rowland Side effects of long-term amiodarone therapy Circulation 67 1983 45 51 (Pubitemid 13222069)
    • (1983) Circulation , vol.67 , Issue.1 , pp. 45-51
    • Harris, L.1    McKenna, W.J.2    Rowland, E.3
  • 363
    • 0021210770 scopus 로고
    • Amiodarone for long-term management of patients with hypertrophic cardiomyopathy
    • DOI 10.1016/S0002-9149(84)80212-X
    • W.J. McKenna, L. Harris, and E. Rowland Amiodarone for long-term management of patients with hypertrophic cardiomyopathy Am J Cardiol 54 1984 802 810 (Pubitemid 14006152)
    • (1984) American Journal of Cardiology , vol.54 , Issue.7 , pp. 802-810
    • McKenna, W.J.1    Harris, L.2    Rowland, E.3
  • 364
    • 0022538803 scopus 로고
    • Amiodarone dose titration: A method to minimise side effects during long term therapy
    • W.J. McKenna, L. Harris, and J.P. Mulrow Amiodarone dose titration: a method to minimise side effects during long term therapy Br J Clin Pract Suppl 44 1986 121 131
    • (1986) Br J Clin Pract Suppl , vol.44 , pp. 121-131
    • McKenna, W.J.1    Harris, L.2    Mulrow, J.P.3
  • 366
    • 0029148123 scopus 로고
    • Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy
    • H. Matsubara, S. Nakatani, and S. Nagata Salutary effect of disopyramide on left ventricular diastolic function in hypertrophic obstructive cardiomyopathy J Am Coll Cardiol 26 1995 768 775
    • (1995) J Am Coll Cardiol , vol.26 , pp. 768-775
    • Matsubara, H.1    Nakatani, S.2    Nagata, S.3
  • 367
    • 23644456310 scopus 로고    scopus 로고
    • Complete pulmonary vein isolation guided by three-dimensional electroanatomical mapping for the treatment of paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy
    • DOI 10.1016/j.eupc.2005.05.015, PII S1099512905002849
    • X. Liu, F. Ouyang, and H. Mavrakis Complete pulmonary vein isolation guided by three-dimensional electroanatomical mapping for the treatment of paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy Europace 7 2005 421 427 (Pubitemid 41130646)
    • (2005) Europace , vol.7 , Issue.5 , pp. 421-427
    • Liu, X.1    Ouyang, F.2    Mavrakis, H.3    Ma, C.4    Dong, J.5    Ernst, S.6    Bansch, D.7    Antz, M.8    Kuck, K.-H.9
  • 368
    • 0842324643 scopus 로고    scopus 로고
    • Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy
    • DOI 10.1016/j.amjcard.2003.10.025
    • M.S. Chen, P.M. McCarthy, and H.M. Lever Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy Am J Cardiol 93 2004 373 375 (Pubitemid 38167444)
    • (2004) American Journal of Cardiology , vol.93 , Issue.3 , pp. 373-375
    • Chen, M.S.1    McCarthy, P.M.2    Lever, H.M.3    Smedira, N.G.4    Lytle, B.L.5
  • 370
  • 371
    • 1242337467 scopus 로고    scopus 로고
    • Pilots, hypertrophic cardiomyopathy, and issues of aviation and public safety
    • DOI 10.1016/j.amjcard.2003.10.038
    • B.J. Maron, J.A. Barry, and R.S. Poole Pilots, hypertrophic cardiomyopathy, and issues of aviation and public safety Am J Cardiol 93 2004 441 444 (Pubitemid 38221352)
    • (2004) American Journal of Cardiology , vol.93 , Issue.4 , pp. 441-444
    • Maron, B.J.1    Barry, J.A.2    Poole, R.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.